
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Are Your kidneys ok? Detect early to protect kidney health - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4813E8AEEC3D305813E000BC0A9B1.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jbrasnefro">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Jornal Brasileiro de Nefrologia">
<meta name="citation_title" content="Are Your kidneys ok? Detect early to protect kidney health">
<meta name="citation_author" content="Joseph A Vassalotti">
<meta name="citation_author_institution" content="Mount Sinai Hospital, Department of Medicine-Renal Medicine, NY, New York, United States.">
<meta name="citation_author" content="Anna Francis">
<meta name="citation_author_institution" content="Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Australia.">
<meta name="citation_author" content="Augusto Cesar Soares Dos Santos, Jr">
<meta name="citation_author_institution" content="Universidade Federal de Minas Gerais, Hospital das Clínicas (EBSERH), Belo Horizonte, MG, Brazil.">
<meta name="citation_author_institution" content="Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil.">
<meta name="citation_author" content="Ricardo Correa-Rotter">
<meta name="citation_author_institution" content="Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.">
<meta name="citation_author" content="Dina Abdellatif">
<meta name="citation_author_institution" content="Cairo University, Cairo University Hospital, Department of Nephrology, Cairo, Egypt.">
<meta name="citation_author" content="Li-Li Hsiao">
<meta name="citation_author_institution" content="Harvard Medical School, Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, MA, USA.">
<meta name="citation_author" content="Stefanos Roumeliotis">
<meta name="citation_author_institution" content="Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Greece.">
<meta name="citation_author" content="Agnes Haris">
<meta name="citation_author_institution" content="Péterfy Hospital, Nephrology Department, Budapest, Hungary.">
<meta name="citation_author" content="Latha A Kumaraswami">
<meta name="citation_author_institution" content="Tamilnad Kidney Research (TANKER) Foundation, Chennai, India.">
<meta name="citation_author" content="Siu-Fai Lui">
<meta name="citation_author_institution" content="The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong.">
<meta name="citation_author" content="Alessandro Balducci">
<meta name="citation_author_institution" content="Italian Kidney Foundation, Rome, Italy.">
<meta name="citation_author" content="Vassilios Liakopoulos">
<meta name="citation_author_institution" content="Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Greece.">
<meta name="citation_publication_date" content="2025 Jul 7">
<meta name="citation_volume" content="47">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="e20250106">
<meta name="citation_doi" content="10.1590/2175-8239-JBN-2025-0106en">
<meta name="citation_pmid" content="40623116">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/pdf/2175-8239-jbn-47-4-e20250106.pdf">
<meta name="description" content="Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to ...">
<meta name="og:title" content="Are Your kidneys ok? Detect early to protect kidney health">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12233814">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1590/2175-8239-JBN-2025-0106en"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/2175-8239-jbn-47-4-e20250106.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12233814%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12233814/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12233814/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jbrasnefro.gif" alt="Jornal Brasileiro de Nefrologia logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Jornal Brasileiro de Nefrologia" title="Link to Jornal Brasileiro de Nefrologia" shape="default" href="http://www.bjn.org.br/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<span class="usa-tag pmc-tag-pt">editorial</span> <div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Bras Nefrol</button></div>. 2025 Jul 7;47(4):e20250106. doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2025-0106en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2025-0106en</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Bras%20Nefrol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><div class="font-secondary font-xs">
<span>View full-text in </span><a href="#s1" class="text-primary">Portuguese</a>
</div>
<section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Are Your kidneys ok? Detect early to protect kidney health</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vassalotti%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Joseph A Vassalotti</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Joseph A Vassalotti</span></h3>
<div class="p">
<sup>1</sup>Mount Sinai Hospital, Department of Medicine-Renal Medicine, NY, New York, United States.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vassalotti%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph A Vassalotti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Francis%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Anna Francis</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Anna Francis</span></h3>
<div class="p">
<sup>2</sup>Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Australia.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Francis%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna Francis</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santos%20ACSD%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></h3>
<div class="p">
<sup>3</sup>Universidade Federal de Minas Gerais, Hospital das Clínicas (EBSERH), Belo Horizonte, MG, Brazil.</div>
<div class="p">
<sup>4</sup>Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santos%20ACSD%22%5BAuthor%5D" class="usa-link"><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Correa-Rotter%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ricardo Correa-Rotter</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ricardo Correa-Rotter</span></h3>
<div class="p">
<sup>5</sup>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Correa-Rotter%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ricardo Correa-Rotter</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdellatif%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Dina Abdellatif</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Dina Abdellatif</span></h3>
<div class="p">
<sup>6</sup>Cairo University, Cairo University Hospital, Department of Nephrology, Cairo, Egypt.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdellatif%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dina Abdellatif</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsiao%20LL%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Li-Li Hsiao</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Li-Li Hsiao</span></h3>
<div class="p">
<sup>7</sup>Harvard Medical School, Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, MA, USA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsiao%20LL%22%5BAuthor%5D" class="usa-link"><span class="name western">Li-Li Hsiao</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roumeliotis%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Stefanos Roumeliotis</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Stefanos Roumeliotis</span></h3>
<div class="p">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Greece.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roumeliotis%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefanos Roumeliotis</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haris%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Agnes Haris</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Agnes Haris</span></h3>
<div class="p">
<sup>9</sup>Péterfy Hospital, Nephrology Department, Budapest, Hungary.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haris%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Agnes Haris</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumaraswami%20LA%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Latha A Kumaraswami</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Latha A Kumaraswami</span></h3>
<div class="p">
<sup>10</sup>Tamilnad Kidney Research (TANKER) Foundation, Chennai, India.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumaraswami%20LA%22%5BAuthor%5D" class="usa-link"><span class="name western">Latha A Kumaraswami</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lui%20SF%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Siu-Fai Lui</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Siu-Fai Lui</span></h3>
<div class="p">
<sup>11</sup>The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lui%20SF%22%5BAuthor%5D" class="usa-link"><span class="name western">Siu-Fai Lui</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balducci%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Alessandro Balducci</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Alessandro Balducci</span></h3>
<div class="p">
<sup>12</sup>Italian Kidney Foundation, Rome, Italy.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balducci%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alessandro Balducci</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liakopoulos%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Vassilios Liakopoulos</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Vassilios Liakopoulos</span></h3>
<div class="p">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Greece.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liakopoulos%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Vassilios Liakopoulos</span></a>
</div>
</div>
<sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Mount Sinai Hospital, Department of Medicine-Renal Medicine, NY, New York, United States.</div>
<div id="aff2">
<sup>2</sup>Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Australia.</div>
<div id="aff3">
<sup>3</sup>Universidade Federal de Minas Gerais, Hospital das Clínicas (EBSERH), Belo Horizonte, MG, Brazil.</div>
<div id="aff4">
<sup>4</sup>Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil.</div>
<div id="aff5">
<sup>5</sup>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.</div>
<div id="aff6">
<sup>6</sup>Cairo University, Cairo University Hospital, Department of Nephrology, Cairo, Egypt.</div>
<div id="aff7">
<sup>7</sup>Harvard Medical School, Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, MA, USA.</div>
<div id="aff8">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Greece.</div>
<div id="aff9">
<sup>9</sup>Péterfy Hospital, Nephrology Department, Budapest, Hungary.</div>
<div id="aff10">
<sup>10</sup>Tamilnad Kidney Research (TANKER) Foundation, Chennai, India.</div>
<div id="aff11">
<sup>11</sup>The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong.</div>
<div id="aff12">
<sup>12</sup>Italian Kidney Foundation, Rome, Italy.</div>
<div class="author-notes p">
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">
<strong>Correspondence to:</strong> Stefanos Roumeliotis. Email: <span>st_roumeliotis@hotmail.com</span>
</p>
</div>
<div class="fn" id="FN1"><p>World Kidney Day Joint Steering Committee</p></div>
<div class="fn" id="fn2"><p><strong>Conflict of Interest:</strong> The authors declare that they have no conflict of interest related to the publication of this manuscript.</p></div>
<div class="fn" id="FN2"><p><strong>Editorial Responsibility:</strong> Editor-in-chief: Thyago Proença de Moraes <a href="https://orcid.org/0000-0002-2983-3968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0002-2983-3968</a>.</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 19; Accepted 2025 Apr 21; Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12233814  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40623116/" class="usa-link">40623116</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask “<em>Are your kidneys ok</em>?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. On this World Kidney Day, we emphasize that case-finding in high-risk populations or even population level screening can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for, and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure, and awareness of kidney disease among healthcare professionals and the general population. Coordinated efforts by major kidney non-governmental organizations to prioritise the kidney health agenda for governments and align early detection efforts with other current programs will maximise efficiency.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Mass Screening, Case Finding, Renal Insufficiency, Chronic, Albuminuria, Proteinuria, Disease Prevention</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Timely treatment is the primary strategy to protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and prevent premature kidney-related and cardiovascular mortality<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. International population assessments show low awareness, low detection of kidney disease, and substantial gaps in treatment<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup>. People with kidney failure universally express their desire for having been diagnosed early in their disease trajectory to allow more time for educational, lifestyle and pharmacologic interventions<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>
</sup>. Therefore, increasing knowledge and implementing sustainable solutions for early detection of kidney disease to protect kidney health are public health priorities<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>.</p>
<section id="sec2"><h3 class="pmc_sec_title">Epidemiology and Complications of Kidney Disease</h3>
<p>CKD (chronic kidney disease) is a prevalent condition, affecting 10% of the world’s population or over 700 million people<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. Almost 80% of the population with CKD reside in low-income countries (LICs) and lower-middle-income countries (LMICs), with approximately 1/3 of the known affected population living in China and India alone<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B6" class="usa-link" aria-describedby="B6">6</a>
</sup>. Prevalence of CKD increased by 33% between 1990 and 2017<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. Increasing prevalence of CKD is driven by population growth, aging, and the obesity epidemic, which increases the prevalence of two major risk factors for CKD: type-2 diabetes (T2DM) and hypertension. In addition, risk factors for CKD beyond cardiometabolic conditions contribute to the rising burden of kidney disease, including social deprivation, pregnancy-related acute kidney injury (AKI), preterm birth, and increasing environmental threats (infections, toxins, climate change, air pollution)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>
</sup>. These threats disproportionately affect people in LICs and LMICs<sup>
<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>.</p>
<p>Undetected and untreated CKD is more likely to progress to kidney failure and cause premature morbidity and mortality. Globally, more people died in 2019 of cardiovascular disease (CVD) attributed to reduced kidney function (1.7 million people) than kidney disease alone (1.4 million)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. CKD is expected to rise to the 5<sup>th</sup> most common cause of years of life lost by 2040, surpassing type 2 diabetes, Alzheimer’s disease and road injuries<sup>
<a href="#B9" class="usa-link" aria-describedby="B9">9</a>
</sup>. The rising mortality of kidney disease is remarkable in contrast to other non-communicable diseases (NCDs) such as CVD, stroke, and respiratory disease, which are projected to experience a decline in mortality<sup>
<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>. Even in early stage CKD, multi-system morbidity decreases quality of life. In particular, mild cognitive impairment is associated with early stage CKD and it is possible that early CKD detection and treatment could slow cognitive decline and reduce the risk of dementia<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>. CKD in children has profound additional effects, threatening growth and cognitive development and having lifelong health and quality of life implications<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>,<a href="#B12" class="usa-link" aria-describedby="B12">12</a>
</sup>. The number of people on kidney failure replacement therapy (KFRT) – dialysis and transplantation – is anticipated to more than double to 5.4 million from 2010 to 2030<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>
</sup>. KFRT, especially hemodialysis, is unavailable or unaffordable to many in LICs and LMICs, contributing to millions of deaths annually. LICs and LMICs comprise 48% of the global population but account for only 7% of the treated kidney failure population<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">Who is at Risk of Kidney Disease?</h2>
<p>Testing people at high-risk of kidney disease (case-finding) limits potential harms and false-positive test results compared to screening the general population, wich should only be considered in high-income countries (HICs). Limiting testing to those at increased risk of CKD would still capture a large proportion of the global population. Moreover, targeted case-finding in patients at high risk of CKD, is not optimally performed even in HICs. About 1 in 3 people worldwide have diabetes and/or hypertension. There is a bidirectional relationship between cardiovascular disease and CKD, with each increasing the risk of the other. The American Heart Association and European Society of Cardiology call for testing those with cardiovascular disease for CKD, as part of routine cardiovascular assessments<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>.</p>
<p>Other CKD risk factors include family history of kidney disease (e.g. APOL1-mediated kidney disease common in people of West African ancestry), prior AKI, pregnancy-related kidney disease (e.g. pre-eclampsia), malignancy, autoimmune disorders (systemic lupus erythematosus, vasculitis), individuals born with low birth weight or pre-term, obstructive uropathy, recurrent kidney stones, and congenital anomalies of the kidney and urinary tract (CAKUT) (see <a href="#F1" class="usa-link">Figure 1</a>)<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. The social determinants of health strongly affect CKD risk, both for individuals and at country level. In the LICs and LMICs, heat stress is thought to cause CKD of unknown etiology in agricultural workers, an increasingly recognized major global cause of CKD<sup>
<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>. In addition, envenomations, environmental toxins, traditional medicines and infections (viral hepatitis B or C, HIV, and parasites) deserve consideration as risk groups, especially in endemic areas<sup>
<a href="#B18" class="usa-link" aria-describedby="B18">18</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<figure class="fig xbox font-sm" id="F1"><h3 class="obj_head">Figure 1. Risk factors for CKD.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f38/12233814/129737a78338/2175-8239-jbn-47-4-e20250106-gf01.jpg" loading="lazy" height="373" width="661" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec4"><h2 class="pmc_sec_title">How can we check Kidney Health?</h2>
<p>Conceptually, there are three levels of CKD prevention. Primary prevention reduces the incidence of CKD by treating risk factors; secondary prevention reduces progression and complications in those with detected CKD; and tertiary prevention improves outcomes in those with kidney failure by improving management, such as improved vaccination or optimal dialysis delivery<sup>
<a href="#B20" class="usa-link" aria-describedby="B20">20</a>
</sup>. Primary and secondary prevention strategies can utilise the 8 golden rules for kidney health promotion; healthy diet, adequate hydration, physical activity, blood pressure monitoring and control, glycaemic monitoring and control, avoidance of nicotine, avoidance of regular use of non-steroidal anti-inflammatory drugs, and targeted testing for those with risk factors<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>
</sup>. Five of these are identical to ‘Life’s Essential 8’ rules for improving and maintaining cardiovascular health, which also include healthy weight, adequate sleep, and lipid management<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>
</sup>. Early detection focuses on secondary CKD prevention, which involves protecting kidney health and reducing cardiovascular risk.</p>
<section id="sec5"><h3 class="pmc_sec_title">Are Your Kidneys Okay?</h3>
<p>Globally, early detection of CKD is rare, haphazard, and even less likely to occur in LICs or LMICs. Currently, only three countries have a national program to actively test at-risk populations for CKD, and a further 17 countries actively test at-risk populations during routine health screening<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. Even in HICs, albuminuria is not assessed in over half of people with T2DM and/or hypertension<sup>
<a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>. Startlingly, in those with documented reduced kidney function, a diagnosis of CKD is often missing. A study in HICs showed absence of CKD diagnosis among 62-96% of the population with laboratory evidence of CKD stage G3<sup>
<a href="#B27" class="usa-link" aria-describedby="B27">27</a>
</sup>.</p>
<p>We recommend that healthcare professionals perform the following tests for all risk groups to assess kidney health (<a href="#F2" class="usa-link">Figure 2</a>): </p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">a)</span><p class="display-inline">Blood pressure measurements, as hypertension is the most prevalent risk factor for kidney disease worldwide<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">b)</span><p class="display-inline">Body mass index (BMI), since obesity is epidemiologically associated with CKD risk indirectly through T2DM and hypertension and as an independent risk factor. Visceral adiposity contributes to monocyte microinflammation and cardiometabolic kidney risk<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">c)</span><p class="display-inline">Glycosylated haemoglobin or fasting blood sugar or random glucose, as T2DM is a common risk factor for kidney disease<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">d)</span><p class="display-inline">Evaluating kidney function by using serum creatinine to estimate GFR (eGFR), is recommended in all settings<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. GFR should be estimated with a validated, race-free equation appropriate for the country or region and age group<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. In general, eGFR &lt; 60 mL/min/1.73m<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup> is the threshold for CKD in adults and children, although a threshold of &lt; 90 mL/min/1.73m<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup> can be flagged as “low” in children and adolescents over the age of 2 years<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. A limitation of creatinine-based eGFR is that creatinine is also a marker of nutrition and muscle mass. Therefore, states of malnutrition and frailty overestimate kidney function<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>. Thus, eGFR combining serum creatinine and cystatin C is generally more accurate than either biomarker alone in most clinical contexts. However, the feasibility of cystatin C use is mainly limited to HICs because of assay availability and cost of creatinine<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>,<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
</li>
<li>
<span class="label">e)</span><p class="display-inline">Testing for kidney damage (albuminuria). In adults and children, a first morning urine sample is preferred for assessing albuminuria<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. In adults, quantitative urinary albumin-creatinine ratio (uACR) is preferred as the most sensitive test<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Importantly, urinary albumin is in the process of being standardized analytically, which should ultimately facilitate worldwide uACR standardization<sup>
<a href="#B32" class="usa-link" aria-describedby="B32">32</a>
</sup>. In children, both protein-creatinine ratio (uPCR) and uACR should be tested in order to assess tubular proteinuria<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Semiquantitative albuminuria testing allows for flexibility for point-of-care or home-based testing<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. Semiquantitative or qualitative screening tests should be positive in &gt;85% of individuals with quantitative uACR 30 mg/g or more to be useful<sup>
<a href="#B34" class="usa-link" aria-describedby="B34">34</a>
</sup>. In resource-constrained settings, urine protein dipstick testing may be used with a threshold of +2 proteinuria or greater to reduce false positive results for repeat confirmatory testing<sup>
<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>.</p>
</li>
</ul>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Conceptual framework of a CKD testing, risk stratification, and treatment program, see reference<sup>
<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f38/12233814/dfd8dd66ab68/2175-8239-jbn-47-4-e20250106-gf02.jpg" loading="lazy" height="302" width="666" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>In specific populations, the following can be considered: </p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">f)</span><p class="display-inline">Testing for haematuria, which has been known as the forgotten risk factor in recent clinical practice guidelines, is particularly important for those at risk for glomerular disease, particularly IgA nephropathy<sup>
<a href="#B36" class="usa-link" aria-describedby="B36">36</a>
</sup>.</p>
</li>
<li>
<span class="label">g)</span><p class="display-inline">Baseline imaging in groups with signs or symptoms of structural abnormalities (e.g. pain and haematuria) to evaluate for kidney masses, cysts, stones, hydronephrosis or urinary retention is important. Antenatal ultrasound can detect hydronephrosis and other CAKUT.</p>
</li>
<li>
<span class="label">h)</span><p class="display-inline">With increasing availability of genetic testing, family cascade CKD testing is indicated when there is a known genetic risk of kidney disease<sup>
<a href="#B37" class="usa-link" aria-describedby="B37">37</a>
</sup>.</p>
</li>
<li>
<span class="label">i)</span><p class="display-inline">In those who have an occupational risk of developing kidney disease, kidney testing should be offered as part of occupational health programs.</p>
</li>
<li>
<span class="label">j)</span><p class="display-inline">Those who donate kidneys should be included in a post-donation surveillance program to assess kidney health over the long-term<sup>
<a href="#B38" class="usa-link" aria-describedby="B38">38</a>
</sup>.</p>
</li>
</ul></section></section><section id="sec6"><h2 class="pmc_sec_title">Potential Benefits of Early Detection</h2>
<p>Screening for CKD fits with many of the World Health Organisation’s Wilson-Jungner principles. Early stage CKD is asymptomatic and effective treatments, including lifestyle modification, interdisciplinary care, and pharmacologic interventions, are established<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>,<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>. WHO essential medicines that improve CKD outcomes, including ACE inhibitors, angiotensin receptor blockers, statins, and sodium glucose co-transporter-2 inhibitors (SGLT2i), should be widely available<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B39" class="usa-link" aria-describedby="B39">39</a>
</sup>. SGLT2i alone are estimated to decrease the risk of CKD progression by 37% in people with and without diabetes<sup>
<a href="#B40" class="usa-link" aria-describedby="B40">40</a>
</sup>. For a 50-year old person with albuminuria and non-diabetic CKD, this could extend the period of healthy kidney function from 9.6 years to 17 years<sup>
<a href="#B41" class="usa-link" aria-describedby="B41">41</a>
</sup>. These essential medicines reduce progression to more advanced CKD stages and limit cardiovascular hospitalization to provide short-term cost-effectiveness, especially in LICs. Where available and affordable, the range of new paradigm-shifting medications to slow CKD progression also includes glucagon-like peptide-1 receptor antagonists, non-steroidal mineralocorticoid receptor antagonists, endothelin receptor antagonists, and specific disease-modifying drugs (e.g. complement-inhibitors) that herald an exciting new era for nephrology.</p>
<p>Considering the significant healthcare costs associated with CKD, particularly hospitalization and kidney failure, effective preventive measures offer clear economic benefits for both high- and low-income countries. CKD confers enormous costs to the individual, their families, healthcare systems, and governments worldwide. In the United States, CKD costs Medicare over US$ 85 billion annually<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>
</sup>. In many high- and middle-income countries, 2–4% of the health budget is spent on kidney failure care alone. In Europe, healthcare costs associated with CKD are higher than those associated with cancer or diabetes<sup>
<a href="#B42" class="usa-link" aria-describedby="B42">42</a>
</sup>. Reducing the burden of kidney care worldwide will also have profound environmental effects, as it will save water and reduce plastic waste, especially associated with dialysis<sup>
<a href="#B43" class="usa-link" aria-describedby="B43">43</a>
</sup>. On an individual level, CKD costs are frequently catastrophic, particularly in LICs and LMICs, where the individual largely bears the burden of payment. Only 13% of LICs and 19% of LMICs cover the costs of KFRT for adults<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>. CKD causes 188 million people in low and lower-middle-income countries annually to be faced with catastrophic healthcare expenditures<sup>
<a href="#B44" class="usa-link" aria-describedby="B44">44</a>
</sup>.</p>
<p>The most widely cited and studied incremental cost effectiveness ratio (ICER) threshold to assess screening is US$ &lt;50,000 per quality-adjusted life year (QALY)<sup>
<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. If the prevalence of CKD is high, a population-wide screening strategy should be considered in HIC<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>,<a href="#B46" class="usa-link" aria-describedby="B46">46</a>
</sup>. For example, in the United States, a recent Markov simulation model of population-wide screening for CKD, which included appropriate SGLT2i treatment added to standard of care ACE inhibitors or angiotensin receptor blockers for adults age 35 to 75 years old with albuminuria, concluded that screening to identify CKD would be cost-effective<sup>
<a href="#B46" class="usa-link" aria-describedby="B46">46</a>
</sup>. In addition, an analysis of a home-based general population semiquantitative albuminuria screening in Holland was also found to be cost effective<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. Case finding to detect CKD in higher risk groups rather than mass or general population screening will reduce costs and other harms whilst increasing the true positive rate of the screening tests<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B35" class="usa-link" aria-describedby="B35">35</a>,<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. An alternate ICER threshold proposed by WHO is &lt;1–3 times the ratio of the gross domestic product per capita income per QALY, which can be used to assess case finding approaches in LIC and LMIC<sup>
<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. The recommended tests for detecting kidney disease are low-cost and minimally invasive, facilitating their administration across diverse settings. Basic testing of eGFR and urinary ACR are widely available, and using urine dipstick testing where quantitative proteinuria testing is unavailable or unaffordable will drastically reduce testing costs<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
<p>If coupled with effective intervention, early identification of people with kidney disease will benefit the individual, the health care system, governments, and the economy<sup>
<a href="#B44" class="usa-link" aria-describedby="B44">44</a>
</sup>. Health and quality of life benefits for the individual would lead to improved productivity, especially in the young who have more working years ahead, and to developmental/educational improvements in children and young adults. Individuals would face less catastrophic health expenses, gov­ernments and healthcare systems will save money not only on CKD care, but also on cardiovascular disease costs, and economies will benefit from higher worker participation. This is especially crucial for low-income countries where the burden of CKD is where gov­ernments and individuals cannot afford kidney care.</p></section><section id="sec7"><h2 class="pmc_sec_title">Challenges and Solutions for Implementation</h2>
<p>Structural barriers to widespread identification and treatment of people with CKD include cost, test reliability, and lack of health information systems to track CKD burden. These are underpinned by a lack of relevant government and healthcare policies, low healthcare professional knowledge and implementation, low perceived kidney disease risk in the general population, and low patient CKD awareness. Solutions for implementing effective interventions include tying CKD identification to existing screening programs, educating the public and primary care professionals, and leveraging non-governmental organization (NGO) joint advocacy programs to focus health policy agendas on kidney disease. Any solutions must balance the potential benefits and harms of screening and case-finding programs. Ethical implications for consideration include the availability of resources (such as health care workers and medicines), the affordability of testing and treatment, false positives or negatives, and anxiety for patients and their families<sup>
<a href="#B47" class="usa-link" aria-describedby="B47">47</a>
</sup>.</p>
<p>Screening and case-finding programs require workforce capacity, health information systems, reliable testing equipment and equitable access to medical care, medicines, vaccines and medical technologies. Primary care is at the front line of the battle to protect kidney health, particularly in low and low-to-middle-income countries. The tiny nephrology workforce, with a median global prevalence of 11.8 nephrologists per million population and an 80-fold discrepancy between LICs and HICs, is inadequate to detect and manage the vast majority of CKD<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. As for other chronic diseases, primary care clinicians and other frontline health workers are foundational to early detection of CKD<sup>
<a href="#B48" class="usa-link" aria-describedby="B48">48</a>
</sup>. Testing must be affordable, simple, and practical, with point-of-care creatinine testing and urine dipsticks useful in resource-limited settings<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>. Educational efforts directed at primary care clinicians are key to integrating CKD detection into routine care, despite constrained time and resources<sup>
<a href="#B49" class="usa-link" aria-describedby="B49">49</a>,<a href="#B50" class="usa-link" aria-describedby="B50">50</a>,<a href="#B51" class="usa-link" aria-describedby="B51">51</a>
</sup>. Automated clinical decision support could leverage electronic health records to identify people with CKD or at high-risk of CKD and recommend appropriate actions to clinicians (<a href="#F2" class="usa-link">Figure 2</a>).</p>
<p>Currently, few countries have CKD registries, limiting our ability to highlight the disease burden to governments. Knowledge of CKD burden helps prioritize kidney health needs, which should then progressively expand to encompass the full spectrum of kidney care<sup>
<a href="#B52" class="usa-link" aria-describedby="B52">52</a>
</sup>. A global survey revealed that only a quarter of the countries (41/162) had a nation-specific CKD strategy and fewer than a third (48/162) recognized CKD as a public health priority<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. WHO’s recognition of CKD as a major driver of NCD mortality would be effective in increasing awareness, improving local surveillance and monitoring to implement clinical practice guidelines, and improving resource allocation<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup>.</p>
<p>Programs for the early detection of CKD will require extensive coordination and engagement of stakeholders, including governments, health systems, and insurers. International and national kidney organisations, such as the International Society of Nephrology (ISN), already advocate to the WHO and individual governments for the prioritisation of kidney disease. We must continue this work, collaborating to streamline early detection program planning and implementation. The integration with existing community programs (e.g. cardiovascular disease prevention) in LMICs and HICs can decrease cost and maximize efficiencies. Such programs will need to be adapted to the local context and can be held in a variety of settings, such as individual healthcare practices, hospitals, regional or national healthcare facilities or as outreach to rural communities. Depending on local regulations and resources, screening and case-finding can also take place outside of medical settings such as town halls, churches, or markets. Volunteers in the community can also assist with community-based screening and case-finding efforts.</p>
<p>In conjunction with refocusing the clinical practice of health care professionals on the timely detection of CKD, we must focus on educating the general population about perceived risk and on health promotion activities and educational programs to raise awareness and empower patients. Awareness of kidney disease is poor, with 9 out of 10 people with CKD not knowing that they are affected<sup>
<a href="#B53" class="usa-link" aria-describedby="B53">53</a>
</sup>. Kidney disease is poorly covered in the lay press, and an analysis showed that kidney disease was 11-times less-represented compared to the actual cause of death<sup>
<a href="#B54" class="usa-link" aria-describedby="B54">54</a>
</sup>. A number of national and international organizations have developed quizzes on risk of kidney disease for the general public. This was supported by a regional study that showed that socially vulnerable patients with hypertension do not understand their kidney risks<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>,<a href="#B55" class="usa-link" aria-describedby="B55">55</a>,<a href="#B56" class="usa-link" aria-describedby="B56">56</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>. Online and in-person education for healthcare professionals can improve consumer health literacy. Patient activation, engagement, and shared decision-making are down­stream impacts of awareness. CKD awareness is nuanced, including detection and risk stratification to inform and empower, rather than scare, regarding the timing and extent of interventions (see <a href="#T1" class="usa-link">Chart 1</a>)<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>. Finding the right balance will optimize patient, family, and caregiver self-efficacy and engagement.</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Chart 1. 
<span class="font-variant-small-caps">Are your kidneys okay? personal perspectives on CKD awareness, detection and treatment from the literature</span>
<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>
.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr><td align="left" valign="top" rowspan="1" colspan="1">I actually didn’t fully understand why nobody had actually given me the full information of what I had in a way that I could kind of go, ‘Well this is what I’ve got [CKD], and this is why I’ve got it.’</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">They [the clinicians] can answer those [kidney health] questions, ... but it’s all very jargonistic.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">I didn’t know what it [CKD] meant so I couldn’t really share it with other people.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">I may not know what my [kidney health] numbers are, but I do know what the tests are, and I do know that I’ve had them done before.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Well, let me put this way: I’m now well aware of the significance of the kidneys and about what the issues are here. And I would definitely consider... When I go to the doctor, I would say to him, “Now, listen. You did the blood tests. But how are my kidneys doing? What are the numbers?</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">I know that they have done urine tests in the past, and I know protein and sugar was in my urine.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">I went from never taking a tablet to taking 22 tablets. What is going on here? I didn’t know what they were. But I just number them and that did help me a lot because I realized what was going on but some of them, every time I went there [to see the doctor], I’d get another tablet. I knew that I had to take it because they knew what they were doing, the doctors that I went to see.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">This [CKD] is something new, so immediately I was like, just another thing to be concerned about. But then I felt kind of empowered, and like I really do want to get ahead of this thing. I feel like I do want to have a conversation with my primary care physician.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">What I would be mostly interested in is what is happening, why is it happening, and what can I do to slow it [CKD] down?</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec8"><h2 class="pmc_sec_title">Conclusion: A Call to Action</h2>
<p>We call on all healthcare professionals to check the kidney health of their patients at risk of kidney disease. In tandem, we must work with public health organizations to improve the general population’s perceived risk of kidney disease and empower people at risk to seek kidney health checks. To ensure this change can be delivered, we must work with healthcare systems, governments, and the WHO to prioritize kidney disease and create effective and efficient early detection programs for kidney disease. Only then will the paradigm-shifting benefits of lifestyle change and pharmacologic treatments translate to better kidney and overall health for people all around the world.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors thank the members of the World Kidney Day Joint Steering Committee — Valerie A. Luyckx, Marcello Tonelli, Ifeoma Ulasi, Vivekanand Jha, Marina Wainstein, Siddiq Anwar, Daniel O’Hara, Elliot K. Tannor, Jorge Cerda, Elena Cervantes, and María Carlota González Bedat — for their invaluable feedback on this paper.</p></section><section id="sec9"><h2 class="pmc_sec_title">Data Availability</h2>
<p>There is no new data associated with this article.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al.  A synopsis of the evidence for the science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636–64. doi: 10.1161/CIR.0000000000001186.</cite> [<a href="https://doi.org/10.1161/CIR.0000000000001186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37807920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=A%20synopsis%20of%20the%20evidence%20for%20the%20science%20and%20Clinical%20Management%20of%20Cardiovascular-Kidney-Metabolic%20(CKM)%20syndrome:%20a%20scientific%20statement%20from%20the%20American%20Heart%20Association&amp;author=CE%20Ndumele&amp;author=IJ%20Neeland&amp;author=KR%20Tuttle&amp;author=SL%20Chow&amp;author=RO%20Mathew&amp;volume=148&amp;issue=20&amp;publication_year=2023&amp;pages=1636-64&amp;pmid=37807920&amp;doi=10.1161/CIR.0000000000001186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, et al.  Mind the gap in kidney care: translating what we know into what we do. Kidney Int. 2024;105(3):406–17. doi: 10.1016/j.kint.2023.12.003.</cite> [<a href="https://doi.org/10.1016/j.kint.2023.12.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38375622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Mind%20the%20gap%20in%20kidney%20care:%20translating%20what%20we%20know%20into%20what%20we%20do&amp;author=VA%20Luyckx&amp;author=KR%20Tuttle&amp;author=D%20Abdellatif&amp;author=R%20Correa-Rotter&amp;author=WWS%20Fung&amp;volume=105&amp;issue=3&amp;publication_year=2024&amp;pages=406-17&amp;pmid=38375622&amp;doi=10.1016/j.kint.2023.12.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al.  KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4):S117–314. doi: 10.1016/j.kint.2023.10.018.</cite> [<a href="https://doi.org/10.1016/j.kint.2023.10.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38490803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=KDIGO%202024%20Clinical%20Practice%20Guideline%20for%20the%20Evaluation%20and%20Management%20of%20Chronic%20Kidney%20Disease&amp;author=PE%20Stevens&amp;author=SB%20Ahmed&amp;author=JJ%20Carrero&amp;author=B%20Foster&amp;author=A%20Francis&amp;volume=105&amp;issue=4&amp;publication_year=2024&amp;pages=S117-314&amp;pmid=38490803&amp;doi=10.1016/j.kint.2023.10.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Guha C, Lopez-Vargas P, Ju A, Gutman T, Scholes-Robertson NJ, Baumgart A, et al.  Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop report. BMJ Open. 2020;10(11):e040617. doi: 10.1136/bmjopen-2020-040617.</cite> [<a href="https://doi.org/10.1136/bmjopen-2020-040617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7646342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33154061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Patient%20needs%20and%20priorities%20for%20patient%20navigator%20programmes%20in%20chronic%20kidney%20disease:%20a%20workshop%20report&amp;author=C%20Guha&amp;author=P%20Lopez-Vargas&amp;author=A%20Ju&amp;author=T%20Gutman&amp;author=NJ%20Scholes-Robertson&amp;volume=10&amp;issue=11&amp;publication_year=2020&amp;pages=e040617&amp;pmid=33154061&amp;doi=10.1136/bmjopen-2020-040617&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>GBD Chronic Kidney Disease Collaboration  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. doi: 10.1016/S0140-6736(20)30045-3.</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)30045-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32061315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Global,%20regional,%20and%20national%20burden%20of%20chronic%20kidney%20disease,%201990-2017:%20a%20systematic%20analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202017&amp;volume=395&amp;issue=10225&amp;publication_year=2020&amp;pages=709-33&amp;pmid=32061315&amp;doi=10.1016/S0140-6736(20)30045-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Cojuc-Konigsberg G, Guijosa A, Moscona-Nissan A, Nordmann-Gomes A, Canaviri-Flores VA, Braverman-Poyastro A, et al.  Representation of low- and middle-income countries in CKD drug trials: a systematic review. Am J Kidney Dis. 2024 doi: 10.1053/j.ajkd.2024.06.012.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2024.06.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39117096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Representation%20of%20low-%20and%20middle-income%20countries%20in%20CKD%20drug%20trials:%20a%20systematic%20review&amp;author=G%20Cojuc-Konigsberg&amp;author=A%20Guijosa&amp;author=A%20Moscona-Nissan&amp;author=A%20Nordmann-Gomes&amp;author=VA%20Canaviri-Flores&amp;publication_year=2024&amp;pmid=39117096&amp;doi=10.1053/j.ajkd.2024.06.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Hsiao LL, Shah KM, Liew A, Abdellatif D, Balducci A, Haris A, et al.  Kidney health for all: preparedness for the unexpected in supporting the vulnerable. Kidney Int. 2023;103(3):436–43. doi: 10.1016/j.kint.2022.12.013.</cite> [<a href="https://doi.org/10.1016/j.kint.2022.12.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36822747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Kidney%20health%20for%20all:%20preparedness%20for%20the%20unexpected%20in%20supporting%20the%20vulnerable&amp;author=LL%20Hsiao&amp;author=KM%20Shah&amp;author=A%20Liew&amp;author=D%20Abdellatif&amp;author=A%20Balducci&amp;volume=103&amp;issue=3&amp;publication_year=2023&amp;pages=436-43&amp;pmid=36822747&amp;doi=10.1016/j.kint.2022.12.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al.  Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473–85. doi: 10.1038/s41581-024-00820-6.</cite> [<a href="https://doi.org/10.1038/s41581-024-00820-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38570631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Chronic%20kidney%20disease%20and%20the%20global%20public%20health%20agenda:%20an%20international%20consensus&amp;author=A%20Francis&amp;author=MN%20Harhay&amp;author=ACM%20Ong&amp;author=SL%20Tummalapalli&amp;author=A%20Ortiz&amp;volume=20&amp;issue=7&amp;publication_year=2024&amp;pages=473-85&amp;pmid=38570631&amp;doi=10.1038/s41581-024-00820-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al.  Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90. doi: 10.1016/S0140-6736(18)31694-5.</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)31694-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6227505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30340847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Forecasting%20life%20expectancy,%20years%20of%20life%20lost,%20and%20all-cause%20and%20cause-specific%20mortality%20for%20250%20causes%20of%20death:%20reference%20and%20alternative%20scenarios%20for%202016%E2%80%9340%20for%20195%20countries%20and%20territories&amp;author=KJ%20Foreman&amp;author=N%20Marquez&amp;author=A%20Dolgert&amp;author=K%20Fukutaki&amp;author=N%20Fullman&amp;volume=392&amp;issue=10159&amp;publication_year=2018&amp;pages=2052-90&amp;pmid=30340847&amp;doi=10.1016/S0140-6736(18)31694-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al.  Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16(8):452–69. doi: 10.1038/s41581-020-0266-9.</cite> [<a href="https://doi.org/10.1038/s41581-020-0266-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32235904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Mechanisms%20of%20cognitive%20dysfunction%20in%20CKD&amp;author=D%20Viggiano&amp;author=CA%20Wagner&amp;author=G%20Martino&amp;author=M%20Nedergaard&amp;author=C%20Zoccali&amp;volume=16&amp;issue=8&amp;publication_year=2020&amp;pages=452-69&amp;pmid=32235904&amp;doi=10.1038/s41581-020-0266-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Chen K, Didsbury M, van Zwieten A, Howell M, Kim S, Tong A, et al.  Neurocognitive and educational outcomes in children and adolescents with CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2018;13(3):387–97. doi: 10.2215/CJN.09650917.</cite> [<a href="https://doi.org/10.2215/CJN.09650917" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5967677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29472306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Neurocognitive%20and%20educational%20outcomes%20in%20children%20and%20adolescents%20with%20CKD:%20a%20systematic%20review%20and%20meta-analysis&amp;author=K%20Chen&amp;author=M%20Didsbury&amp;author=A%20van%20Zwieten&amp;author=M%20Howell&amp;author=S%20Kim&amp;volume=13&amp;issue=3&amp;publication_year=2018&amp;pages=387-97&amp;pmid=29472306&amp;doi=10.2215/CJN.09650917&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, et al.  Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch Dis Child. 2019;104(2):134–40. doi: 10.1136/archdischild-2018-314934.</cite> [<a href="https://doi.org/10.1136/archdischild-2018-314934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30018070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Dis%20Child&amp;title=Quality%20of%20life%20of%20children%20and%20adolescents%20with%20chronic%20kidney%20disease:%20a%20cross-sectional%20study&amp;author=A%20Francis&amp;author=MS%20Didsbury&amp;author=A%20van%20Zwieten&amp;author=K%20Chen&amp;author=LJ%20James&amp;volume=104&amp;issue=2&amp;publication_year=2019&amp;pages=134-40&amp;pmid=30018070&amp;doi=10.1136/archdischild-2018-314934&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>United States Renal Data System  . 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2023. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=2023%20USRDS%20Annual%20Data%20Report:%20Epidemiology%20of%20kidney%20disease%20in%20the%20United%20States&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82. doi: 10.1016/S0140-6736(14)61601-9.</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)61601-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25777665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Worldwide%20access%20to%20treatment%20for%20end-stage%20kidney%20disease:%20a%20systematic%20review&amp;author=T%20Liyanage&amp;author=T%20Ninomiya&amp;author=V%20Jha&amp;author=B%20Neal&amp;author=HM%20Patrice&amp;volume=385&amp;issue=9981&amp;publication_year=2015&amp;pages=1975-82&amp;pmid=25777665&amp;doi=10.1016/S0140-6736(14)61601-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, et al.  Assessment of Global Kidney Health Care Status. JAMA. 2017;317(18):1864–81. doi: 10.1001/jama.2017.4046.</cite> [<a href="https://doi.org/10.1001/jama.2017.4046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5470418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28430830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Assessment%20of%20Global%20Kidney%20Health%20Care%20Status&amp;author=AK%20Bello&amp;author=A%20Levin&amp;author=M%20Tonelli&amp;author=IG%20Okpechi&amp;author=J%20Feehally&amp;volume=317&amp;issue=18&amp;publication_year=2017&amp;pages=1864-81&amp;pmid=28430830&amp;doi=10.1001/jama.2017.4046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Ortiz A, Wanner C, Gansevoort R, Ortiz A, Wanner C, Gansevoort RT, et al.  Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. Nephrol Dial Transplant. 2023;38(3):527–31. doi: 10.1093/ndt/gfac257.</cite> [<a href="https://doi.org/10.1093/ndt/gfac257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9976739/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36216362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Chronic%20kidney%20disease%20as%20cardiovascular%20risk%20factor%20in%20routine%20clinical%20practice:%20a%20position%20statement%20by%20the%20Council%20of%20the%20European%20Renal%20Association&amp;author=A%20Ortiz&amp;author=C%20Wanner&amp;author=R%20Gansevoort&amp;author=A%20Ortiz&amp;author=C%20Wanner&amp;volume=38&amp;issue=3&amp;publication_year=2023&amp;pages=527-31&amp;pmid=36216362&amp;doi=10.1093/ndt/gfac257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Johnson RJ, Wesseling C, Newman LS. Chronic kidney disease of unknown cause in agricultural communities. N Engl J Med. 2019;380(19):1843–52. doi: 10.1056/NEJMra1813869.</cite> [<a href="https://doi.org/10.1056/NEJMra1813869" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31067373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Chronic%20kidney%20disease%20of%20unknown%20cause%20in%20agricultural%20communities&amp;author=RJ%20Johnson&amp;author=C%20Wesseling&amp;author=LS%20Newman&amp;volume=380&amp;issue=19&amp;publication_year=2019&amp;pages=1843-52&amp;pmid=31067373&amp;doi=10.1056/NEJMra1813869&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>McCulloch M, Luyckx VA, Cullis B, Davies SJ, Finkelstein FO, Yap HK, et al.  Challenges of access to kidney care for children in low-resource settings. Nat Rev Nephrol. 2021;17(1):33–45. doi: 10.1038/s41581-020-00338-7.</cite> [<a href="https://doi.org/10.1038/s41581-020-00338-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33005036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Challenges%20of%20access%20to%20kidney%20care%20for%20children%20in%20low-resource%20settings&amp;author=M%20McCulloch&amp;author=VA%20Luyckx&amp;author=B%20Cullis&amp;author=SJ%20Davies&amp;author=FO%20Finkelstein&amp;volume=17&amp;issue=1&amp;publication_year=2021&amp;pages=33-45&amp;pmid=33005036&amp;doi=10.1038/s41581-020-00338-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016;31(6):868–74. doi: 10.1093/ndt/gfv466.</cite> [<a href="https://doi.org/10.1093/ndt/gfv466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4876969/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27217391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Chronic%20kidney%20disease%20in%20low-%20and%20middle-income%20countries&amp;author=JW%20Stanifer&amp;author=A%20Muiru&amp;author=TH%20Jafar&amp;author=UD%20Patel&amp;volume=31&amp;issue=6&amp;publication_year=2016&amp;pages=868-74&amp;pmid=27217391&amp;doi=10.1093/ndt/gfv466&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522–35. doi: 10.1053/j.ajkd.2008.11.019.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2008.11.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19231739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Comprehensive%20public%20health%20strategies%20for%20preventing%20the%20development,%20progression,%20and%20complications%20of%20CKD:%20report%20of%20an%20expert%20panel%20convened%20by%20the%20Centers%20for%20Disease%20Control%20and%20Prevention&amp;author=AS%20Levey&amp;author=AC%20Schoolwerth&amp;author=NR%20Burrows&amp;author=DE%20Williams&amp;author=KR%20Stith&amp;volume=53&amp;issue=3&amp;publication_year=2009&amp;pages=522-35&amp;pmid=19231739&amp;doi=10.1053/j.ajkd.2008.11.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>World Kidney Day [Internet]  2025.  [cited 2025 Apr 23].  Available from:  <a href="https://www.worldkidneyday.org/about-kidney-health/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.worldkidneyday.org/about-kidney-health/</a>
</cite>
</li>
<li id="B22">
<span class="label">22.</span><cite>Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al.  Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18–43. doi: 10.1161/CIR.0000000000001078.</cite> [<a href="https://doi.org/10.1161/CIR.0000000000001078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10503546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35766027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Life%E2%80%99s%20Essential%208:%20Updating%20and%20Enhancing%20the%20American%20Heart%20Association%E2%80%99s%20Construct%20of%20Cardiovascular%20Health:%20a%20presidential%20advisory%20from%20the%20American%20Heart%20Association&amp;author=DM%20Lloyd-Jones&amp;author=NB%20Allen&amp;author=CAM%20Anderson&amp;author=T%20Black&amp;author=LC%20Brewer&amp;volume=146&amp;issue=5&amp;publication_year=2022&amp;pages=e18-43&amp;pmid=35766027&amp;doi=10.1161/CIR.0000000000001078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al.  An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382–95. doi: 10.1016/S2214-109X(23)00570-3.</cite> [<a href="https://doi.org/10.1016/S2214-109X(23)00570-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38365413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Glob%20Health&amp;title=An%20update%20on%20the%20global%20disparities%20in%20kidney%20disease%20burden%20and%20care%20across%20world%20countries%20and%20regions&amp;author=AK%20Bello&amp;author=IG%20Okpechi&amp;author=A%20Levin&amp;author=F%20Ye&amp;author=S%20Damster&amp;volume=12&amp;issue=3&amp;publication_year=2024&amp;pages=e382-95&amp;pmid=38365413&amp;doi=10.1016/S2214-109X(23)00570-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Ferre S, Storfer-Isser A, Kinderknecht K, Montgomery E, Godwin M, Andrews A, et al.  Fulfillment and validity of the kidney health evaluation measure for people with diabetes. Mayo Clin Proc Innov Qual Outcomes. 2023;7(5):382–91. doi: 10.1016/j.mayocpiqo.2023.07.002.</cite> [<a href="https://doi.org/10.1016/j.mayocpiqo.2023.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10480072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37680649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc%20Innov%20Qual%20Outcomes&amp;title=Fulfillment%20and%20validity%20of%20the%20kidney%20health%20evaluation%20measure%20for%20people%20with%20diabetes&amp;author=S%20Ferre&amp;author=A%20Storfer-Isser&amp;author=K%20Kinderknecht&amp;author=E%20Montgomery&amp;author=M%20Godwin&amp;volume=7&amp;issue=5&amp;publication_year=2023&amp;pages=382-91&amp;pmid=37680649&amp;doi=10.1016/j.mayocpiqo.2023.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Alfego D, Ennis J, Gillespie B, Lewis MJ, Montgomery E, Ferre S, et al.  Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a national laboratory database. Diabetes Care. 2021;44(9):2025–32. doi: 10.2337/dc21-0723.</cite> [<a href="https://doi.org/10.2337/dc21-0723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8740927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34353883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Chronic%20kidney%20disease%20testing%20among%20at-risk%20adults%20in%20the%20U.S.%20remains%20low:%20real-world%20evidence%20from%20a%20national%20laboratory%20database&amp;author=D%20Alfego&amp;author=J%20Ennis&amp;author=B%20Gillespie&amp;author=MJ%20Lewis&amp;author=E%20Montgomery&amp;volume=44&amp;issue=9&amp;publication_year=2021&amp;pages=2025-32&amp;pmid=34353883&amp;doi=10.2337/dc21-0723&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Stempniewicz N, Vassalotti JA, Cuddeback JK, Ciemins E, Storfer-Isser A, Sang Y, et al.  Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. Health Care Organizations. Diabetes Care. 2021;44(9):2000–9. doi: 10.2337/dc20-2715.</cite> [<a href="https://doi.org/10.2337/dc20-2715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8740923/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34233925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Chronic%20kidney%20disease%20testing%20among%20primary%20care%20patients%20with%20type%202%20diabetes%20across%2024%20U.S.%20Health%20Care%20Organizations&amp;author=N%20Stempniewicz&amp;author=JA%20Vassalotti&amp;author=JK%20Cuddeback&amp;author=E%20Ciemins&amp;author=A%20Storfer-Isser&amp;volume=44&amp;issue=9&amp;publication_year=2021&amp;pages=2000-9&amp;pmid=34233925&amp;doi=10.2337/dc20-2715&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Kushner PR, DeMeis J, Stevens P, Gjurovic AM, Malvolti E, Tangri N. Patient and clinician perspectives: to create a better future for chronic kidney disease, we need to talk about our kidneys. Adv Ther. 2024;41(4):1318–24. doi: 10.1007/s12325-024-02794-0.</cite> [<a href="https://doi.org/10.1007/s12325-024-02794-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10960902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38443646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Ther&amp;title=Patient%20and%20clinician%20perspectives:%20to%20create%20a%20better%20future%20for%20chronic%20kidney%20disease,%20we%20need%20to%20talk%20about%20our%20kidneys&amp;author=PR%20Kushner&amp;author=J%20DeMeis&amp;author=P%20Stevens&amp;author=AM%20Gjurovic&amp;author=E%20Malvolti&amp;volume=41&amp;issue=4&amp;publication_year=2024&amp;pages=1318-24&amp;pmid=38443646&amp;doi=10.1007/s12325-024-02794-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Farrell DR, Vassalotti JA. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrol. 2024;25(1):34. doi: 10.1186/s12882-024-03466-5.</cite> [<a href="https://doi.org/10.1186/s12882-024-03466-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10809507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38273240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Nephrol&amp;title=Screening,%20identifying,%20and%20treating%20chronic%20kidney%20disease:%20why,%20who,%20when,%20how,%20and%20what?&amp;author=DR%20Farrell&amp;author=JA%20Vassalotti&amp;volume=25&amp;issue=1&amp;publication_year=2024&amp;pages=34&amp;pmid=38273240&amp;doi=10.1186/s12882-024-03466-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Tuttle KR. CKD screening for better kidney health: Why? Who? How? When? Nephrol Dial Transplant. 2024;39(10):1537–9. doi: 10.1093/ndt/gfae055.</cite> [<a href="https://doi.org/10.1093/ndt/gfae055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11427061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38425029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=CKD%20screening%20for%20better%20kidney%20health:%20Why?%20Who?%20How?%20When?&amp;author=KR%20Tuttle&amp;volume=39&amp;issue=10&amp;publication_year=2024&amp;pages=1537-9&amp;pmid=38425029&amp;doi=10.1093/ndt/gfae055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al.  The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;99(1):34–47. doi: 10.1016/j.kint.2020.10.012.</cite> [<a href="https://doi.org/10.1016/j.kint.2020.10.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33127436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=The%20case%20for%20early%20identification%20and%20intervention%20of%20chronic%20kidney%20disease:%20conclusions%20from%20a%20Kidney%20Disease:%20Improving%20Global%20Outcomes%20(KDIGO)%20Controversies%20Conference&amp;author=MG%20Shlipak&amp;author=SL%20Tummalapalli&amp;author=LE%20Boulware&amp;author=ME%20Grams&amp;author=JH%20Ix&amp;volume=99&amp;issue=1&amp;publication_year=2021&amp;pages=34-47&amp;pmid=33127436&amp;doi=10.1016/j.kint.2020.10.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Tummalapalli SL, Shlipak MG, Damster S, Jha V, Malik C, Levin A, et al.  Availability and affordability of kidney health laboratory tests around the globe. Am J Nephrol. 2020;51(12):959–65. doi: 10.1159/000511848.</cite> [<a href="https://doi.org/10.1159/000511848" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8482418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33333515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Nephrol&amp;title=Availability%20and%20affordability%20of%20kidney%20health%20laboratory%20tests%20around%20the%20globe&amp;author=SL%20Tummalapalli&amp;author=MG%20Shlipak&amp;author=S%20Damster&amp;author=V%20Jha&amp;author=C%20Malik&amp;volume=51&amp;issue=12&amp;publication_year=2020&amp;pages=959-65&amp;pmid=33333515&amp;doi=10.1159/000511848&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Seegmiller JC, Bachmann LM. Urine albumin measurements in clinical diagnostics. Clin Chem. 2024;70(2):382–91. doi: 10.1093/clinchem/hvad174.</cite> [<a href="https://doi.org/10.1093/clinchem/hvad174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38321881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Urine%20albumin%20measurements%20in%20clinical%20diagnostics&amp;author=JC%20Seegmiller&amp;author=LM%20Bachmann&amp;volume=70&amp;issue=2&amp;publication_year=2024&amp;pages=382-91&amp;pmid=38321881&amp;doi=10.1093/clinchem/hvad174&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>van Mil D, Kieneker LM, Heerspink HJL, Gansevoort RT. Screening for chronic kidney disease: change of perspective and novel developments. Curr Opin Nephrol Hypertens. 2024;33(6):583–92. doi: 10.1097/MNH.0000000000001016.</cite> [<a href="https://doi.org/10.1097/MNH.0000000000001016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11426989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39137037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Nephrol%20Hypertens&amp;title=Screening%20for%20chronic%20kidney%20disease:%20change%20of%20perspective%20and%20novel%20developments&amp;author=D%20van%20Mil&amp;author=LM%20Kieneker&amp;author=HJL%20Heerspink&amp;author=RT%20Gansevoort&amp;volume=33&amp;issue=6&amp;publication_year=2024&amp;pages=583-92&amp;pmid=39137037&amp;doi=10.1097/MNH.0000000000001016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark A, et al.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2023;69(8):808–68. doi: 10.1093/clinchem/hvad080.</cite> [<a href="https://doi.org/10.1093/clinchem/hvad080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37473453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Guidelines%20and%20recommendations%20for%20laboratory%20analysis%20in%20the%20diagnosis%20and%20management%20of%20diabetes%20mellitus&amp;author=DB%20Sacks&amp;author=M%20Arnold&amp;author=GL%20Bakris&amp;author=DE%20Bruns&amp;author=AR%20Horvath&amp;volume=69&amp;issue=8&amp;publication_year=2023&amp;pages=808-68&amp;pmid=37473453&amp;doi=10.1093/clinchem/hvad080&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Tonelli M, Dickinson JA. Early Detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol. 2020;31(9):1931–40. doi: 10.1681/ASN.2020030277.</cite> [<a href="https://doi.org/10.1681/ASN.2020030277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7461685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32839279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Soc%20Nephrol&amp;title=Early%20Detection%20of%20CKD:%20Implications%20for%20low-income,%20middle-income,%20and%20high-income%20countries&amp;author=M%20Tonelli&amp;author=JA%20Dickinson&amp;volume=31&amp;issue=9&amp;publication_year=2020&amp;pages=1931-40&amp;pmid=32839279&amp;doi=10.1681/ASN.2020030277&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Moreno JA, Martin-Cleary C, Gutierrez E, Rubio-Navarro A, Ortiz A, Praga M, et al.  Haematuria: the forgotten CKD factor? Nephrol Dial Transplant. 2012;27(1):28–34. doi: 10.1093/ndt/gfr749.</cite> [<a href="https://doi.org/10.1093/ndt/gfr749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22287699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Haematuria:%20the%20forgotten%20CKD%20factor?&amp;author=JA%20Moreno&amp;author=C%20Martin-Cleary&amp;author=E%20Gutierrez&amp;author=A%20Rubio-Navarro&amp;author=A%20Ortiz&amp;volume=27&amp;issue=1&amp;publication_year=2012&amp;pages=28-34&amp;pmid=22287699&amp;doi=10.1093/ndt/gfr749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Franceschini N, Feldman DL, Berg JS, Besse W, Chang AR, Dahl NK, et al.  Advancing genetic testing in kidney diseases: report from a national kidney foundation working group. Am J Kidney Dis. 2024;84(6):751–66. doi: 10.1053/j.ajkd.2024.05.010.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2024.05.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11585423/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39033956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Advancing%20genetic%20testing%20in%20kidney%20diseases:%20report%20from%20a%20national%20kidney%20foundation%20working%20group&amp;author=N%20Franceschini&amp;author=DL%20Feldman&amp;author=JS%20Berg&amp;author=W%20Besse&amp;author=AR%20Chang&amp;volume=84&amp;issue=6&amp;publication_year=2024&amp;pages=751-66&amp;pmid=39033956&amp;doi=10.1053/j.ajkd.2024.05.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, et al.  Long-term risks for kidney donors. Kidney Int. 2014;86(1):162–7. doi: 10.1038/ki.2013.460.</cite> [<a href="https://doi.org/10.1038/ki.2013.460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24284516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Long-term%20risks%20for%20kidney%20donors&amp;author=G%20Mj%C3%B8en&amp;author=S%20Hallan&amp;author=A%20Hartmann&amp;author=A%20Foss&amp;author=K%20Midtvedt&amp;volume=86&amp;issue=1&amp;publication_year=2014&amp;pages=162-7&amp;pmid=24284516&amp;doi=10.1038/ki.2013.460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Francis A, Abdul Hafidz MI, Ekrikpo UE, Chen T, Wijewickrama E, Tannor EK, et al.  Barriers to accessing essential medicines for kidney disease in low- and lower middle-income countries|. Kidney Int. 2022;102(5):969–73. doi: 10.1016/j.kint.2022.07.029.</cite> [<a href="https://doi.org/10.1016/j.kint.2022.07.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36044940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Barriers%20to%20accessing%20essential%20medicines%20for%20kidney%20disease%20in%20low-%20and%20lower%20middle-income%20countries%7C&amp;author=A%20Francis&amp;author=MI%20Abdul%20Hafidz&amp;author=UE%20Ekrikpo&amp;author=T%20Chen&amp;author=E%20Wijewickrama&amp;volume=102&amp;issue=5&amp;publication_year=2022&amp;pages=969-73&amp;pmid=36044940&amp;doi=10.1016/j.kint.2022.07.029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Baigent C, Emberson J, Haynes R, Herrington WG, Judge P, Landray MJ, et al.  Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788–801. doi: 10.1016/S0140-6736(22)02074-8.</cite> [<a href="https://doi.org/10.1016/S0140-6736(22)02074-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7613836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36351458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Impact%20of%20diabetes%20on%20the%20effects%20of%20sodium%20glucose%20co-transporter-2%20inhibitors%20on%20kidney%20outcomes:%20collaborative%20meta-analysis%20of%20large%20placebo-controlled%20trials&amp;author=C%20Baigent&amp;author=J%20Emberson&amp;author=R%20Haynes&amp;author=WG%20Herrington&amp;author=P%20Judge&amp;volume=400&amp;issue=10365&amp;publication_year=2022&amp;pages=1788-801&amp;pmid=36351458&amp;doi=10.1016/S0140-6736(22)02074-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Vart P, Vaduganathan M, Jongs N, Remuzzi G, Wheeler DC, Hou FF, et al.  Estimated lifetime benefit of combined RAAS and SGLT2 inhibitor therapy in patients with albuminuric CKD without diabetes. Clin J Am Soc Nephrol. 2022;17(12):1754–62. doi: 10.2215/CJN.08900722.</cite> [<a href="https://doi.org/10.2215/CJN.08900722" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9718016/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36414316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Estimated%20lifetime%20benefit%20of%20combined%20RAAS%20and%20SGLT2%20inhibitor%20therapy%20in%20patients%20with%20albuminuric%20CKD%20without%20diabetes&amp;author=P%20Vart&amp;author=M%20Vaduganathan&amp;author=N%20Jongs&amp;author=G%20Remuzzi&amp;author=DC%20Wheeler&amp;volume=17&amp;issue=12&amp;publication_year=2022&amp;pages=1754-62&amp;pmid=36414316&amp;doi=10.2215/CJN.08900722&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393–409. doi: 10.1038/nrneph.2017.63.</cite> [<a href="https://doi.org/10.1038/nrneph.2017.63" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28555652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Nephrol&amp;title=Reducing%20the%20costs%20of%20chronic%20kidney%20disease%20while%20delivering%20quality%20health%20care:%20a%20call%20to%20action&amp;author=R%20Vanholder&amp;author=L%20Annemans&amp;author=E%20Brown&amp;author=R%20Gansevoort&amp;author=JJ%20Gout-Zwart&amp;volume=13&amp;issue=7&amp;publication_year=2017&amp;pages=393-409&amp;pmid=28555652&amp;doi=10.1038/nrneph.2017.63&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Berman-Parks N, Berman-Parks I, Gómez-Ruíz IA, Ardavin-Ituarte JM, Piccoli GB. Combining patient care and environmental protection: a pilot program recycling polyvinyl chloride from automated peritoneal dialysis waste. Kidney Int Rep. 2024;9(6):1908–11. doi: 10.1016/j.ekir.2024.03.008.</cite> [<a href="https://doi.org/10.1016/j.ekir.2024.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11184240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38899205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Rep&amp;title=Combining%20patient%20care%20and%20environmental%20protection:%20a%20pilot%20program%20recycling%20polyvinyl%20chloride%20from%20automated%20peritoneal%20dialysis%20waste&amp;author=N%20Berman-Parks&amp;author=I%20Berman-Parks&amp;author=IA%20G%C3%B3mez-Ru%C3%ADz&amp;author=JM%20Ardavin-Ituarte&amp;author=GB%20Piccoli&amp;volume=9&amp;issue=6&amp;publication_year=2024&amp;pages=1908-11&amp;pmid=38899205&amp;doi=10.1016/j.ekir.2024.03.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>Essue BM, Laba M, Knaul F, Chu A, Minh HV, Nguyen TKP, et al.   In: Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries. Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, et al., editors. Washington, DC: The International Bank for Reconstruction and Developmen; 2017. Disease Control Priorities: Improving Health and Reducing Poverty; pp. 121–43.</cite> [<a href="https://doi.org/10.1596/978-1-4648-0527-1_ch6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30212160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Economic%20Burden%20of%20Chronic%20Ill%20Health%20and%20Injuries%20for%20Households%20in%20Low-%20and%20Middle-Income%20Countries&amp;author=BM%20Essue&amp;author=M%20Laba&amp;author=F%20Knaul&amp;author=A%20Chu&amp;author=HV%20Minh&amp;publication_year=2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>Yeo SC, Wang H, Ang YG, Lim CK, Ooi XY. Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review. Clin Kidney J. 2024;17(1):137. doi: 10.1093/ckj/sfad137.</cite> [<a href="https://doi.org/10.1093/ckj/sfad137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10765095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38186904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Kidney%20J&amp;title=Cost-effectiveness%20of%20screening%20for%20chronic%20kidney%20disease%20in%20the%20general%20adult%20population:%20a%20systematic%20review&amp;author=SC%20Yeo&amp;author=H%20Wang&amp;author=YG%20Ang&amp;author=CK%20Lim&amp;author=XY%20Ooi&amp;volume=17&amp;issue=1&amp;publication_year=2024&amp;pages=137&amp;pmid=38186904&amp;doi=10.1093/ckj/sfad137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD. Population-wide screening for chronic kidney disease : a cost-effectiveness analysis. Ann Intern Med. 2023;176(6):788–97. doi: 10.7326/M22-3228.</cite> [<a href="https://doi.org/10.7326/M22-3228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11091494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37216661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Intern%20Med&amp;title=Population-wide%20screening%20for%20chronic%20kidney%20disease%20:%20a%20cost-effectiveness%20analysis&amp;author=MM%20Cusick&amp;author=RL%20Tisdale&amp;author=GM%20Chertow&amp;author=DK%20Owens&amp;author=JD%20Goldhaber-Fiebert&amp;volume=176&amp;issue=6&amp;publication_year=2023&amp;pages=788-97&amp;pmid=37216661&amp;doi=10.7326/M22-3228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>Yadla M, John P, Fong VK, Anandh U. Ethical issues related to early screening programs in low resource settings. Kidney Int Rep. 2024;9(8):2315–9. doi: 10.1016/j.ekir.2024.06.024.</cite> [<a href="https://doi.org/10.1016/j.ekir.2024.06.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11328672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39156162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Rep&amp;title=Ethical%20issues%20related%20to%20early%20screening%20programs%20in%20low%20resource%20settings&amp;author=M%20Yadla&amp;author=P%20John&amp;author=VK%20Fong&amp;author=U%20Anandh&amp;volume=9&amp;issue=8&amp;publication_year=2024&amp;pages=2315-9&amp;pmid=39156162&amp;doi=10.1016/j.ekir.2024.06.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>Szczech LA, Stewart RC, Su HL, DeLoskey RJ, Astor BC, Fox CH, et al.  Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease) PLoS One. 2014;9(11):e110535. doi: 10.1371/journal.pone.0110535.</cite> [<a href="https://doi.org/10.1371/journal.pone.0110535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4245114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25427285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Primary%20care%20detection%20of%20chronic%20kidney%20disease%20in%20adults%20with%20type-2%20diabetes:%20the%20ADD-CKD%20Study%20(awareness,%20detection%20and%20drug%20therapy%20in%20type%202%20diabetes%20and%20chronic%20kidney%20disease)&amp;author=LA%20Szczech&amp;author=RC%20Stewart&amp;author=HL%20Su&amp;author=RJ%20DeLoskey&amp;author=BC%20Astor&amp;volume=9&amp;issue=11&amp;publication_year=2014&amp;pages=e110535&amp;pmid=25427285&amp;doi=10.1371/journal.pone.0110535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129(2):153–62.e7. doi: 10.1016/j.amjmed.2015.08.025.</cite> [<a href="https://doi.org/10.1016/j.amjmed.2015.08.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26391748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Med&amp;title=Practical%20approach%20to%20detection%20and%20management%20of%20chronic%20kidney%20disease%20for%20the%20primary%20care%20clinician&amp;author=JA%20Vassalotti&amp;author=R%20Centor&amp;author=BJ%20Turner&amp;author=RC%20Greer&amp;author=M%20Choi&amp;volume=129&amp;issue=2&amp;publication_year=2016&amp;pages=153-62.e7&amp;pmid=26391748&amp;doi=10.1016/j.amjmed.2015.08.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>Thavarajah S, Knicely DH, Choi MJ. CKD for primary care practitioners: can we cut to the chase without too many shortcuts? Am J Kidney Dis. 2016;67(6):826–9. doi: 10.1053/j.ajkd.2016.02.043.</cite> [<a href="https://doi.org/10.1053/j.ajkd.2016.02.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27090354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=CKD%20for%20primary%20care%20practitioners:%20can%20we%20cut%20to%20the%20chase%20without%20too%20many%20shortcuts?&amp;author=S%20Thavarajah&amp;author=DH%20Knicely&amp;author=MJ%20Choi&amp;volume=67&amp;issue=6&amp;publication_year=2016&amp;pages=826-9&amp;pmid=27090354&amp;doi=10.1053/j.ajkd.2016.02.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>Vassalotti JA, Boucree SC. Integrating CKD into US Primary Care: bridging the knowledge and implementation gaps. Kidney Int Rep. 2022;7(3):389–96. doi: 10.1016/j.ekir.2022.01.1066.</cite> [<a href="https://doi.org/10.1016/j.ekir.2022.01.1066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8897496/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35257053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Rep&amp;title=Integrating%20CKD%20into%20US%20Primary%20Care:%20bridging%20the%20knowledge%20and%20implementation%20gaps&amp;author=JA%20Vassalotti&amp;author=SC%20Boucree&amp;volume=7&amp;issue=3&amp;publication_year=2022&amp;pages=389-96&amp;pmid=35257053&amp;doi=10.1016/j.ekir.2022.01.1066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>Luyckx VA, Moosa MR. Priority setting as an ethical imperative in managing global dialysis access and improving kidney care. Semin Nephrol. 2021;41(3):230–41. doi: 10.1016/j.semnephrol.2021.05.004.</cite> [<a href="https://doi.org/10.1016/j.semnephrol.2021.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34330363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Nephrol&amp;title=Priority%20setting%20as%20an%20ethical%20imperative%20in%20managing%20global%20dialysis%20access%20and%20improving%20kidney%20care&amp;author=VA%20Luyckx&amp;author=MR%20Moosa&amp;volume=41&amp;issue=3&amp;publication_year=2021&amp;pages=230-41&amp;pmid=34330363&amp;doi=10.1016/j.semnephrol.2021.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>CDC  Chronic Kidney Disease in the United States [Internet] 2023.  [cited 2025 Apr 23].  Available from:  <a href="https://www.cdc.gov/kidneydisease/publications-resources/CKD-national-facts.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/kidneydisease/publications-resources/CKD-national-facts.html</a>
.</cite>
</li>
<li id="B54">
<span class="label">54.</span><cite>Ritchie H. Does the news reflect what we die from? [Internet] 2019.  [cited 2025 Apr 23].  Available from:  <a href="https://ourworldindata.org/does-the-news-reflect-what-we-die-from" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ourworldindata.org/does-the-news-reflect-what-we-die-from</a>
.</cite>
</li>
<li id="B55">
<span class="label">55.</span><cite>Boulware LE, Carson KA, Troll MU, Powe NR, Cooper LA. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med. 2009;24(10):1123–9. doi: 10.1007/s11606-009-1086-6.</cite> [<a href="https://doi.org/10.1007/s11606-009-1086-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2762510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19711135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gen%20Intern%20Med&amp;title=Perceived%20susceptibility%20to%20chronic%20kidney%20disease%20among%20high-risk%20patients%20seen%20in%20primary%20care%20practices&amp;author=LE%20Boulware&amp;author=KA%20Carson&amp;author=MU%20Troll&amp;author=NR%20Powe&amp;author=LA%20Cooper&amp;volume=24&amp;issue=10&amp;publication_year=2009&amp;pages=1123-9&amp;pmid=19711135&amp;doi=10.1007/s11606-009-1086-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>Foundation NK  Kidney Quiz [Internet] 2024.  [cited 2025 Apr 23].  Available from:  <a href="https://www.kidney.org/kidney-quiz/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.kidney.org/kidney-quiz/</a>
</cite>
</li>
<li id="B57">
<span class="label">57.</span><cite>Tuot DS, Crowley ST, Katz LA, Leung J, Alcantara-Cadillo DK, Ruser C, et al.  Usability testing of the kidney score platform to enhance communication about kidney disease in primary care settings: qualitative think-aloud study. JMIR Form Res. 2022;6(9):e40001. doi: 10.2196/40001.</cite> [<a href="https://doi.org/10.2196/40001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9557760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36170008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JMIR%20Form%20Res&amp;title=Usability%20testing%20of%20the%20kidney%20score%20platform%20to%20enhance%20communication%20about%20kidney%20disease%20in%20primary%20care%20settings:%20qualitative%20think-aloud%20study&amp;author=DS%20Tuot&amp;author=ST%20Crowley&amp;author=LA%20Katz&amp;author=J%20Leung&amp;author=DK%20Alcantara-Cadillo&amp;volume=6&amp;issue=9&amp;publication_year=2022&amp;pages=e40001&amp;pmid=36170008&amp;doi=10.2196/40001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" lang="pt" id="s1"><section class="pmc-layout__citation font-secondary font-xs"><div>J Bras Nefrol. 2025 Jul 7;47(4):e20250106. [Article in Portuguese] doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2025-0106pt" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2025-0106pt</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Seus rins estão saudáveis? Faça um diagnóstico precoce para proteger a saúde renal</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vassalotti%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Joseph A Vassalotti</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Joseph A Vassalotti</span></h3>
<div class="p">
<sup>1</sup>Mount Sinai Hospital, Department of Medicine-Renal Medicine, NY, New York, Estados Unidos.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vassalotti%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph A Vassalotti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Francis%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Anna Francis</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Anna Francis</span></h3>
<div class="p">
<sup>2</sup>Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Austrália.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Francis%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anna Francis</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santos%20ACSD%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></h3>
<div class="p">
<sup>3</sup>Universidade Federal de Minas Gerais, Hospital das Clínicas (EBSERH), Belo Horizonte, MG, Brasil.</div>
<div class="p">
<sup>4</sup>Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brasil.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santos%20ACSD%22%5BAuthor%5D" class="usa-link"><span class="name western">Augusto Cesar Soares Dos Santos Jr</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Correa-Rotter%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Ricardo Correa-Rotter</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Ricardo Correa-Rotter</span></h3>
<div class="p">
<sup>5</sup>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Correa-Rotter%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ricardo Correa-Rotter</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdellatif%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Dina Abdellatif</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Dina Abdellatif</span></h3>
<div class="p">
<sup>6</sup>Cairo University, Cairo University Hospital, Department of Nephrology, Cairo, Egito.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdellatif%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dina Abdellatif</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsiao%20LL%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Li-Li Hsiao</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Li-Li Hsiao</span></h3>
<div class="p">
<sup>7</sup>Harvard Medical School, Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, MA, EUA.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hsiao%20LL%22%5BAuthor%5D" class="usa-link"><span class="name western">Li-Li Hsiao</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roumeliotis%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Stefanos Roumeliotis</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Stefanos Roumeliotis</span></h3>
<div class="p">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Grécia.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roumeliotis%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefanos Roumeliotis</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haris%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Agnes Haris</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Agnes Haris</span></h3>
<div class="p">
<sup>9</sup>Péterfy Hospital, Nephrology Department, Budapest, Hungria.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haris%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Agnes Haris</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumaraswami%20LA%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Latha A Kumaraswami</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Latha A Kumaraswami</span></h3>
<div class="p">
<sup>10</sup>Tamilnad Kidney Research (TANKER) Foundation, Chennai, Índia.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumaraswami%20LA%22%5BAuthor%5D" class="usa-link"><span class="name western">Latha A Kumaraswami</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lui%20SF%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Siu-Fai Lui</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Siu-Fai Lui</span></h3>
<div class="p">
<sup>11</sup>The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lui%20SF%22%5BAuthor%5D" class="usa-link"><span class="name western">Siu-Fai Lui</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balducci%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Alessandro Balducci</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Alessandro Balducci</span></h3>
<div class="p">
<sup>12</sup>Italian Kidney Foundation, Rome, Itália.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Balducci%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alessandro Balducci</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liakopoulos%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Vassilios Liakopoulos</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Vassilios Liakopoulos</span></h3>
<div class="p">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Grécia.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liakopoulos%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Vassilios Liakopoulos</span></a>
</div>
</div>
<sup>8</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a.c" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<div class="p" id="aff13">
<sup>1</sup>Mount Sinai Hospital, Department of Medicine-Renal Medicine, NY, New York, Estados Unidos.</div>
<div id="aff14">
<sup>2</sup>Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Austrália.</div>
<div id="aff15">
<sup>3</sup>Universidade Federal de Minas Gerais, Hospital das Clínicas (EBSERH), Belo Horizonte, MG, Brasil.</div>
<div id="aff16">
<sup>4</sup>Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brasil.</div>
<div id="aff17">
<sup>5</sup>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, México.</div>
<div id="aff18">
<sup>6</sup>Cairo University, Cairo University Hospital, Department of Nephrology, Cairo, Egito.</div>
<div id="aff19">
<sup>7</sup>Harvard Medical School, Brigham and Women’s Hospital, Renal Division, Department of Medicine, Boston, MA, EUA.</div>
<div id="aff20">
<sup>8</sup>Aristotle University of Thessaloniki, Medical School, AHEPA University Hospital, Second Department of Nephrology, Thessaloniki, Grécia.</div>
<div id="aff21">
<sup>9</sup>Péterfy Hospital, Nephrology Department, Budapest, Hungria.</div>
<div id="aff22">
<sup>10</sup>Tamilnad Kidney Research (TANKER) Foundation, Chennai, Índia.</div>
<div id="aff23">
<sup>11</sup>The Chinese University of Hong Kong, Jockey Club School of Public Health and Primary Care, Division of Health System, Policy and Management, Hong Kong.</div>
<div id="aff24">
<sup>12</sup>Italian Kidney Foundation, Rome, Itália.</div>
<div class="author-notes p">
<div class="fn" id="c002">
<sup>✉</sup><p class="display-inline">
<strong>Correspondência para:</strong> Stefanos Roumeliotis. E-mail: <span>st_roumeliotis@hotmail.com</span>
</p>
</div>
<div class="fn" id="FN3"><p>Comitê Diretor Conjunto do Dia Mundial do Rim</p></div>
<div class="fn" id="fn5"><p><strong>Conflito de Interesse:</strong> Os autores declaram não haver conflito de interesses relacionado à publicação deste manuscrito.</p></div>
<div class="fn" id="FN4"><p><strong>Responsabilidade Editorial:</strong> Editor chefe: Thyago Proença de Moraes <a href="https://orcid.org/0000-0002-2983-3968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0002-2983-3968</a>.</p></div>
</div>
</div>
<div id="anp_a.c" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub1" class="history"><p>Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><section class="abstract" id="abstract2"><h2>Resumo</h2>
<p>A identificação precoce da doença renal pode proteger a saúde dos rins, prevenir a progressão da doença e complicações relacionadas, reduzir o risco de doenças cardiovasculares e diminuir a mortalidade. Devemos questionar “<em>Seus rins estão saudáveis</em>?” utilizando creatinina sérica para estimar a função renal e albumina urinária para avaliar lesões renais e endoteliais. A avaliação das causas e dos fatores de risco para a doença renal crônica (DRC) inclui testes para diabetes e medição da pressão arterial e do índice de massa corporal. Neste Dia Mundial do Rim, enfatizamos que a detecção de casos em populações de alto risco, ou mesmo a triagem em nível populacional, pode reduzir o ônus da doença renal globalmente. A DRC em estágio inicial é assintomática, facilmente diagnosticável e os recentes tratamentos, que representam uma mudança de paradigma, como inibidores do cotransportador de sódio-glicose tipo 2, promovem uma melhora significativa nos desfechos da doença e favorecem a análise custo-benefício para programas de triagem ou detecção de casos. Apesar disso, existem diversos obstáculos, incluindo a alocação de recursos, o financiamento da saúde, a infraestrutura dos serviços de saúde e a conscientização sobre a doença renal entre profissionais da saúde e a população em geral. Esforços coordenados pelas principais organizações não governamentais dedicadas a doenças renais, com o objetivo de priorizar a agenda de saúde renal junto aos governos e alinhar as iniciativas de detecção precoce com outros programas atuais, irão maximizar a eficiência.</p>
<section id="kwd-group2" class="kwd-group"><p><strong>Descritores:</strong> Programas de Rastreamento, Detecção de casos, Insuficiência Renal Crônica, Albuminúria, Proteinúria, Prevenção de Doenças</p></section></section><section id="sec10"><h2 class="pmc_sec_title">Introdução</h2>
<p>O tratamento oportuno constitui a principal estratégia para proteger a saúde renal, prevenir a progressão da doença renal e complicações relacionadas, reduzir o risco de doenças cardiovasculares e prevenir a mortalidade cardiovascular e renal prematura<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Avaliações populacionais internacionais revelam um baixo nível de conscientização, baixa detecção de doenças renais e lacunas substanciais no tratamento. Indivíduos com insuficiência renal expressam universalmente o desejo de ter sido diagnosticados precocemente ao longo do curso da doença, de modo a dispor de mais tempo para receber intervenções educacionais, farmacológicas e relacionadas ao estilo de vida<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>
</sup>. Portanto, ampliar o conhecimento e implementar soluções sustentáveis para a detecção precoce da doença renal, a fim de proteger a saúde dos rins, são prioridades de saúde pública<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>.</p>
<section id="sec11"><h3 class="pmc_sec_title">Epidemiologia e Complicações da Doença Renal</h3>
<p>A doença renal crônica (DRC) é uma condição prevalente, que afeta 10% da população mundial, o que equivale a mais de 700 milhões de pessoas<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. Quase 80% da população com DRC reside em países de baixa renda (LIC, do inglês <em>low-income countries</em>) e países de renda média-baixa (LMIC, do inglês <em>lower-middle income countries</em>), com aproximadamente 1/3 da população afetada conhecida concentrando-se apenas na China e na Índia<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B6" class="usa-link" aria-describedby="B6">6</a>
</sup>. A prevalência de DRC aumentou 33% entre 1990 e 2017<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. Esse aumento é impulsionado pelo crescimento e envelhecimento populacionais e pela epidemia da obesidade, que elevam a prevalência de dois importantes fatores de risco para a DRC: diabetes tipo 2 (DM2) e hipertensão. Além das condições cardiometabólicas, outros fatores de risco para DRC contribuem para o aumento do ônus da doença renal, incluindo privação social, injúria renal aguda (IRA) relacionada à gestação, parto prematuro e ameaças ambientais crescentes (infecções, toxinas, mudanças climáticas, poluição atmosférica)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>,<a href="#B7" class="usa-link" aria-describedby="B7">7</a>
</sup>. Essas ameaças atingem de maneira desproporcional as populações dos LIC e LMIC<sup>
<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>.</p>
<p>A DRC não detectada e não tratada apresenta maior probabilidade de progredir para insuficiência renal e provocar morbidade e mortalidade prematuras. Mundialmente, mais pessoas foram a óbito em 2019 por doença cardiovascular (DCV) atribuída à redução da função renal (1,7 milhão de pessoas) do que pela doença renal isolada (1,4 milhão)<sup>
<a href="#B5" class="usa-link" aria-describedby="B5">5</a>
</sup>. Estima-se que a DRC se torne a quinta causa mais comum de anos de vida perdidos até 2040, superando o diabetes tipo 2, a doença de Alzheimer e os acidentes de trânsito<sup>
<a href="#B9" class="usa-link" aria-describedby="B9">9</a>
</sup>. O aumento da mortalidade por doença renal é notável, em contraste com outras doenças não transmissíveis (DNTs), como DCV, acidente vascular cerebral e doenças respiratórias, que, segundo as projeções, sofrerão um declínio na mortalidade<sup>
<a href="#B8" class="usa-link" aria-describedby="B8">8</a>
</sup>. Mesmo nos estágios iniciais da DRC, a morbidade multissistêmica reduz a qualidade de vida. Em particular, o comprometimento cognitivo leve está associado ao estágio inicial da DRC e é possível que a detecção e o tratamento precoces da doença possam retardar o declínio cognitivo e reduzir o risco de demência<sup>
<a href="#B10" class="usa-link" aria-describedby="B10">10</a>
</sup>. A DRC em crianças apresenta profundos efeitos adicionais, comprometendo o crescimento e o desenvolvimento cognitivo, além de ter implicações para a saúde e a qualidade de vida ao longo da vida<sup>
<a href="#B11" class="usa-link" aria-describedby="B11">11</a>,<a href="#B12" class="usa-link" aria-describedby="B12">12</a>
</sup>. Espera-se que o número de pessoas em terapia renal substitutiva (TRS) – diálise e transplante – mais do que duplique, chegando a 5,4 milhões entre 2010 e 2030<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>,<a href="#B14" class="usa-link" aria-describedby="B14">14</a>
</sup>. A TRS, especialmente a hemodiálise, não está disponível ou é financeiramente inviável para grande parte da população em LIC e LMIC, contribuindo para milhões de óbitos anualmente. Os LIC e os LMIC compreendem 48% da população global, mas representam somente 7% da população com insuficiência renal tratada<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>.</p></section></section><section id="sec12"><h2 class="pmc_sec_title">Quem está em Risco de Desenvolver Doença Renal?</h2>
<p>A testagem de pessoas com alto risco para doença renal (detecção de casos) limita os potenciais danos e os resultados de testes falso-positivos em comparação com a triagem da população em geral, o que só deve ser considerado em países de alta renda (HICs, do inglês <em>high-income countries</em>). Restringir os testes àqueles que têm maior risco de desenvolver DRC ainda abrangeria uma grande parte da população global. Além disso, a detecção de casos específicos em pacientes com alto risco para DRC não é realizada de forma ideal, mesmo em HICs. Aproximadamente 1 em cada 3 pessoas no mundo tem diabetes e/ou hipertensão. Existe uma relação bidirecional entre a doença cardiovascular e a DRC, em que uma aumenta o risco da outra. A <em>American Heart Association</em> e a <em>European Society of Cardiology</em> recomendam que as pessoas com doenças cardiovasculares sejam testadas para a DRC, como parte das avaliações cardiovasculares de rotina<sup>
<a href="#B1" class="usa-link" aria-describedby="B1">1</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>.</p>
<p>Outros fatores de risco para DRC incluem histórico familiar de doença renal (por exemplo, doença renal mediada por APOL1, comum em indivíduos com ascendência da África Ocidental), IRA anterior, doença renal relacionada à gestação (por exemplo, pré-eclâmpsia), malignidade, distúrbios autoimunes (lúpus eritematoso sistêmico, vasculite), indivíduos nascidos com baixo peso ou pré-termo, uropatia obstrutiva, nefrolitíase recorrente e anomalias congênitas do rim e do trato urinário (CAKUT) (ver <a href="#F3" class="usa-link">Figura 1</a>)<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Os determinantes sociais da saúde influenciam significativamente o risco de desenvolver DRC, tanto em nível individual quanto nacional. Nos LICs e LMICs, acredita-se que o estresse térmico possa causar DRC de etiologia desconhecida em trabalhadores rurais, uma causa mundial de DRC cada vez mais reconhecida<sup>
<a href="#B17" class="usa-link" aria-describedby="B17">17</a>
</sup>. Além disso, envenenamentos, toxinas ambientais, medicamentos tradicionais e infecções (hepatite viral B ou C, HIV e parasitas) merecem ser considerados como grupos de risco, especialmente em áreas endêmicas<sup>
<a href="#B18" class="usa-link" aria-describedby="B18">18</a>,<a href="#B19" class="usa-link" aria-describedby="B19">19</a>
</sup>.</p>
<figure class="fig xbox font-sm" id="F3"><h3 class="obj_head">Figura 1. Fatores de risco para doença renal crônica.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f38/12233814/253462078a14/2175-8239-jbn-47-4-e20250106-gf03.jpg" loading="lazy" height="371" width="666" alt="Figura 1"></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec13"><h2 class="pmc_sec_title">Como Podemos Avaliar a Saúde Renal?</h2>
<p>Conceitualmente, existem três níveis de prevenção da DRC. A prevenção primária reduz a incidência de DRC por meio do tratamento dos fatores de risco; a prevenção secundária reduz a progressão e as complicações naqueles com DRC detectada; e a prevenção terciária melhora os desfechos em pacientes com insuficiência renal, promovendo melhorias no manejo, como vacinação aprimorada ou fornecimento ideal de diálise<sup>
<a href="#B20" class="usa-link" aria-describedby="B20">20</a>
</sup>. As estratégias de prevenção primária e secundária podem utilizar as 8 regras de ouro para a promoção da saúde renal, que incluem: dieta saudável, hidratação adequada, atividade física, monitoramento e controle da pressão arterial, monitoramento e controle glicêmico, evitar o uso de nicotina, evitar o uso regular de anti-inflamatórios não esteroides e testes direcionados para indivíduos com fatores de risco<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>
</sup>. Cinco dessas recomendações são idênticas às regras do “<em>Life’s Essential 8</em>”, que visam à melhoria e à manutenção da saúde cardiovascular, incluindo também peso e sono adequados e manejo de lipídios<sup>
<a href="#B22" class="usa-link" aria-describedby="B22">22</a>
</sup>. A detecção precoce se concentra na prevenção secundária da DRC, que envolve a proteção da saúde renal e a redução do risco cardiovascular.</p>
<section id="sec14"><h3 class="pmc_sec_title">Seus Rins Estão Saudáveis?</h3>
<p>Mundialmente, a detecção precoce da DRC é rara, irregular e ainda menos provável de ocorrer em LICs ou LMICs. Atualmente, somente três países possuem um programa nacional voltado à testagem ativa de populações em risco para DRC, e outros 17 países testam ativamente populações em risco durante exames de saúde de rotina<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. Mesmo em HICs, a albuminúria não é avaliada em mais da metade dos indivíduos com DM2 e/ou hipertensão<sup>
<a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a>,<a href="#B26" class="usa-link" aria-describedby="B26">26</a>
</sup>. Surpreendentemente, naqueles com função renal reduzida documentada, o diagnóstico de DRC geralmente não é realizado. Um estudo em HICs revelou ausência de diagnóstico de DRC entre 62–96% da população com evidência laboratorial de DRC estágio G3<sup>
<a href="#B27" class="usa-link" aria-describedby="B27">27</a>
</sup>.</p>
<p>Recomendamos que os profissionais de saúde realizem os seguintes exames em todos os grupos de risco, a fim de avaliar a saúde renal (<a href="#F4" class="usa-link">Figura 2</a>): </p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">a)</span><p class="display-inline">Medições da pressão arterial, uma vez que a hipertensão é o fator de risco mais prevalente para doença renal em todo o mundo<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">b)</span><p class="display-inline">Índice de massa corporal (IMC), já que a obesidade está epidemiologicamente associada ao risco de DRC, de forma indireta por meio de DM2 e hipertensão e como um fator de risco independente. A adiposidade visceral contribui para a microinflamação por monócitos e o risco cardiometabólico renal<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">c)</span><p class="display-inline">Hemoglobina glicada, glicemia de jejum ou teste aleatório de glicose, visto que o DM2 é um fator de risco comum para doença renal<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B28" class="usa-link" aria-describedby="B28">28</a>,<a href="#B29" class="usa-link" aria-describedby="B29">29</a>
</sup>.</p>
</li>
<li>
<span class="label">d)</span><p class="display-inline">A avaliação da função renal por meio da creatinina sérica para estimar a TFG (TFGe) é recomendada em todos os contextos<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. A TFG deve ser estimada com uma equação validada, livre de ajustes para raça e adequada ao país ou região e à faixa etária<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Em geral, uma TFGe &lt; 60 mL/min/1,73m<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup> é o limite para DRC em adultos e crianças, embora um limite de &lt; 90 mL/min/1,73m<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup> possa ser sinalizado como “baixo” em crianças e adolescentes com idade superior a 2 anos<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Uma limitação da TFGe baseada na creatinina é o fato de a creatinina também ser um biomarcador de nutrição e massa muscular. Portanto, estados de desnutrição e fragilidade superestimam a função renal<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>. Dessa forma, a TFGe que combina creatinina sérica e cistatina C é geralmente mais precisa do que o uso isolado de qualquer um dos biomarcadores na maioria dos contextos clínicos. No entanto, a viabilidade do uso da cistatina C é limitada principalmente aos HICs devido à disponibilidade do ensaio e ao custo da creatinina<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>,<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
</li>
<li>
<span class="label">e)</span><p class="display-inline">Teste de lesão renal (albuminúria). Em adultos e crianças, recomenda-se uma amostra da primeira urina da manhã para avaliação da albuminúria<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Em adultos, a relação albumina-creatinina urinária (RACu) quantitativa é preferível, por ser o teste mais sensível<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. Importante ressaltar que a albumina urinária encontra-se em processo de padronização dos métodos analíticos, o que, em última instância, deve facilitar a padronização mundial da RACu<sup>
<a href="#B32" class="usa-link" aria-describedby="B32">32</a>
</sup>. Em crianças, tanto a relação proteína-creatinina (RPCu) quanto a RACu devem ser testadas com o objetivo de avaliar a proteinúria tubular<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>
</sup>. O teste semiquantitativo de albuminúria permite flexibilidade para a realização de testes no local de atendimento (“<em>point-of-care</em>”) ou em ambiente domiciliar<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. Testes de triagem semiquantitativos ou qualitativos devem apresentar positividade em &gt;85% dos indivíduos com RACu quantitativa de 30 mg/g ou mais para serem considerados úteis<sup>
<a href="#B34" class="usa-link" aria-describedby="B34">34</a>
</sup>. Em ambientes com recursos limitados, pode-se utilizar o teste de tira reagente para proteína na urina, com um limite de proteinúria igual ou superior a + 2, visando reduzir os resultados falso-positivos para repetição do teste confirmatório<sup>
<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>.</p>
</li>
</ul>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figura 2. Estrutura conceitual para testes, estratificação de risco e programa de tratamento da doença renal crônica (DRC), ver referência<sup>
<a href="#B30" class="usa-link" aria-describedby="B30">30</a>
</sup>.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f38/12233814/3096a0a95d43/2175-8239-jbn-47-4-e20250106-gf04.jpg" loading="lazy" height="290" width="666" alt="Figura 2"></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Em populações específicas, podem ser considerados os seguintes testes: </p>
<ul class="list" style="list-style-type:none">
<li>
<span class="label">f)</span><p class="display-inline">Exames para hematúria – conhecida atualmente como fator de risco esquecido em diretrizes recentes de prática clínica – são particularmente importantes para aqueles com risco de doença glomerular, especialmente nefropatia por IgA<sup>
<a href="#B36" class="usa-link" aria-describedby="B36">36</a>
</sup>.</p>
</li>
<li>
<span class="label">g)</span><p class="display-inline">É importante a realização de exames de imagem iniciais (basais) em grupos com sinais ou sintomas sugestivos de anormalidades estruturais (por exemplo, dor e hematúria), com o objetivo de avaliar massas renais, cistos, cálculos, hidronefrose ou retenção urinária. A ultrassonografia pré-natal pode detectar hidronefrose e outras CAKUT.</p>
</li>
<li>
<span class="label">h)</span><p class="display-inline">Com a crescente disponibilidade de testes genéticos, o teste em cascata para DRC familiar é indicado quando há um risco genético conhecido de doença renal<sup>
<a href="#B37" class="usa-link" aria-describedby="B37">37</a>
</sup>.</p>
</li>
<li>
<span class="label">i)</span><p class="display-inline">Em indivíduos com risco ocupacional de desenvolver doença renal, o exame renal deve ser oferecido como parte dos programas de saúde ocupacional.</p>
</li>
<li>
<span class="label">j)</span><p class="display-inline">Indivíduos doadores de rins devem ser incluídos em programas de vigilância pós-doação para avaliar a saúde renal em longo prazo<sup>
<a href="#B38" class="usa-link" aria-describedby="B38">38</a>
</sup>.</p>
</li>
</ul></section></section><section id="sec15"><h2 class="pmc_sec_title">Benefícios Potenciais da Detecção Precoce</h2>
<p>A triagem para DRC está de acordo com muitos dos princípios de Wilson-Jungner da Organização Mundial da Saúde. A DRC em estágio inicial é assintomática, e existem tratamentos eficazes estabelecidos, incluindo modificação do estilo de vida, cuidados interdisciplinares e intervenções farmacológicas<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>,<a href="#B35" class="usa-link" aria-describedby="B35">35</a>
</sup>. Medicamentos essenciais da OMS que melhoram os desfechos da DRC, incluindo inibidores da ECA, bloqueadores dos receptores de angiotensina, estatinas e inibidores do cotransportador de sódio-glicose tipo 2 (SGLT2i), devem estar amplamente disponíveis<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>,<a href="#B39" class="usa-link" aria-describedby="B39">39</a>
</sup>. Estima-se que os SGLT2i, isoladamente, reduzam o risco de progressão da DRC em 37% em indivíduos com e sem diabetes<sup>
<a href="#B40" class="usa-link" aria-describedby="B40">40</a>
</sup>. Para uma pessoa de 50 anos com albuminúria e DRC não diabética, esses resultados poderiam estender o período de função renal saudável de 9,6 anos para 17 anos<sup>
<a href="#B41" class="usa-link" aria-describedby="B41">41</a>
</sup>. Esses medicamentos essenciais reduzem a progressão para estágios mais avançados da DRC e limitam a hospitalização por causas cardiovasculares, proporcionando custo-benefício em curto prazo, especialmente nos países de baixa renda. Quando disponíveis e acessíveis, a gama de novos medicamentos transformadores de paradigmas destinados a retardar a progressão da DRC também inclui antagonistas do receptor do peptídeo-1 semelhante ao glucagon, antagonistas dos receptores mineralocorticoides não esteroidais, antagonistas dos receptores de endotelina e medicamentos específicos modificadores da doença (como inibidores do complemento) que anunciam uma nova e promissora era para a nefrologia.</p>
<p>Considerando os custos significativos de saúde associados à DRC, especialmente de hospitalização e insuficiência renal, medidas preventivas eficazes oferecem benefícios econômicos evidentes tanto para países de alta quanto de baixa renda. A DRC impõe custos expressivos aos indivíduos, suas famílias, sistemas de saúde e governos em todo o mundo. Nos Estados Unidos, a DRC representa um custo anual de mais de US$ 85 bilhões para o sistema Medicare<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>
</sup>. Em muitos países de alta e média renda, 2 a 4% do orçamento destinado à saúde é gasto apenas com os cuidados com a insuficiência renal. Na Europa, os custos de saúde associados à DRC superam os associados ao câncer ou ao diabetes<sup>
<a href="#B42" class="usa-link" aria-describedby="B42">42</a>
</sup>. A redução do ônus do tratamento renal em todo o mundo também trará efeitos ambientais significativos, uma vez que proporcionará economia de água e reduzirá o desperdício de plástico, especialmente associado à diálise<sup>
<a href="#B43" class="usa-link" aria-describedby="B43">43</a>
</sup>. Em nível individual, os custos da DRC são frequentemente calamitosos, especialmente em LICs e LMICs, onde o ônus do pagamento recai em grande parte sobre o próprio paciente. Somente 13% dos LICs e 19% dos LMICs cobrem os custos da TRS para adultos<sup>
<a href="#B15" class="usa-link" aria-describedby="B15">15</a>
</sup>. A DRC leva 188 milhões de pessoas em países de baixa e média-baixa renda a enfrentarem anualmente despesas catastróficas com a saúde<sup>
<a href="#B44" class="usa-link" aria-describedby="B44">44</a>
</sup>.</p>
<p>O limite da razão de custo-efetividade incremental (ICER, <em>Incremental Cost Effectiveness Ratio</em>) mais amplamente citado e estudado para avaliar a triagem é de US$ &lt;50.000 por ano de vida ajustado à qualidade (QALY)<sup>
<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. Caso a prevalência de DRC seja elevada, uma estratégia de triagem em toda a população deve ser considerada em HICs<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>,<a href="#B46" class="usa-link" aria-describedby="B46">46</a>
</sup>. Por exemplo, nos Estados Unidos, um modelo recente de simulação de Markov para triagem populacional de DRC, que incluiu o tratamento adequado com SGLT2i somado ao tratamento padrão com inibidores da ECA ou bloqueadores dos receptores de angiotensina para adultos de 35 a 75 anos com albuminúria, concluiu que a triagem para identificar DRC seria custo-efetiva<sup>
<a href="#B46" class="usa-link" aria-describedby="B46">46</a>
</sup>. Além disso, uma análise de uma triagem semiquantitativa de albuminúria da população geral, realizada em ambiente domiciliar na Holanda, também demonstrou ser custo-efetiva<sup>
<a href="#B33" class="usa-link" aria-describedby="B33">33</a>
</sup>. A detecção de casos para identificar a DRC em grupos de risco mais elevado, em vez da triagem em massa ou da população geral, reduzirá os custos e outros possíveis danos, ao mesmo tempo em que aumentará a taxa de verdadeiros positivos nos testes de triagem<sup>
<a href="#B3" class="usa-link" aria-describedby="B3">3</a>,<a href="#B35" class="usa-link" aria-describedby="B35">35</a>,<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. Um limite alternativo de ICER proposto pela OMS é de &lt;1-3 vezes a razão do produto interno bruto per capita por QALY, que pode ser utilizado para avaliar abordagens de detecção de casos em LIC e LMIC<sup>
<a href="#B45" class="usa-link" aria-describedby="B45">45</a>
</sup>. Os testes recomendados para a detecção da doença renal são de baixo custo e minimamente invasivos, facilitando sua administração em diversos contextos.</p>
<p>Os testes básicos de TFGe e RAC urinária estão amplamente disponíveis, e o uso do teste de urina com fita reagente nos casos em que o teste quantitativo de proteinúria não está disponível ou é inacessível reduzirá drasticamente os custos dos testes<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
<p>Se associada a intervenções eficazes, a identificação precoce de indivíduos com doença renal beneficiará o indivíduo, o sistema de saúde, os governos e a economia<sup>
<a href="#B44" class="usa-link" aria-describedby="B44">44</a>
</sup>. Os benefícios à saúde e à qualidade de vida do indivíduo resultariam em maior produtividade, especialmente para os jovens que possuem mais anos de atividade profissional pela frente, e em melhorias no desenvolvimento/educação de crianças e jovens adultos. Os indivíduos enfrentariam menos despesas catastróficas com a saúde, os governos e os sistemas de saúde economizariam dinheiro não apenas nos cuidados com a DRC, mas também nos custos com doenças cardiovasculares, e as economias se beneficiariam de uma maior participação no mercado de trabalho. Trata-se de algo particularmente crucial para os países de baixa renda, onde o ônus da DRC recai sobre os governos e os indivíduos que não podem arcar com os custos dos cuidados renais.</p></section><section id="sec16"><h2 class="pmc_sec_title">Desafios e Soluções Para a Implementação</h2>
<p>As barreiras estruturais para a ampla identificação e o tratamento de pessoas com DRC incluem custo, confiabilidade dos testes e falta de sistemas de informações de saúde para rastrear o ônus da DRC. Essas são sustentadas pela falta de políticas governamentais e de saúde relevantes, baixo conhecimento e implementação por parte dos profissionais de saúde, baixa percepção do risco de doença renal na população em geral e baixa conscientização da DRC por parte dos pacientes.</p>
<p>As soluções para a implementação de intervenções eficazes incluem vincular a identificação da DRC aos programas de triagem existentes, educar o público e os profissionais da atenção primária e aproveitar os programas de defesa conjunta de organizações não governamentais (ONGs) para que as agendas de políticas de saúde se concentrem na doença renal. Qualquer solução deve equilibrar os potenciais benefícios e danos dos programas de triagem e detecção de casos. As implicações éticas a serem consideradas incluem a disponibilidade de recursos (como profissionais de saúde e medicamentos), a viabilidade econômica dos testes e do tratamento, falsos positivos ou negativos e a ansiedade dos pacientes e de suas famílias<sup>
<a href="#B47" class="usa-link" aria-describedby="B47">47</a>
</sup>.</p>
<p>Os programas de triagem e detecção de casos exigem capacidade da força de trabalho, sistemas de informação em saúde, equipamentos de teste confiáveis e acesso equitativo a cuidados médicos, medicamentos, vacinas e tecnologias em saúde.</p>
<p>A atenção primária está na linha de frente da batalha para proteger a saúde renal, principalmente em países de baixa renda e países de renda média-baixa. A reduzida força de trabalho em nefrologia, com uma prevalência global mediana de 11,8 nefrologistas por milhão de habitantes e uma discrepância de 80 vezes entre LICs e HICs, é inadequada para a detecção e o manejo da grande maioria dos casos de DRC<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. Assim como em outras doenças crônicas, os médicos da atenção primária e outros profissionais de saúde da linha de frente são fundamentais para a detecção precoce da DRC<sup>
<a href="#B48" class="usa-link" aria-describedby="B48">48</a>
</sup>. Os testes devem ser acessíveis, simples e práticos, sendo que o teste <em>point of care</em> de creatinina e as fitas reagentes para análise de urina são úteis em locais com recursos limitados<sup>
<a href="#B31" class="usa-link" aria-describedby="B31">31</a>
</sup>.</p>
<p>Esforços educacionais direcionados aos médicos da atenção primária são fundamentais para integrar a detecção da DRC à rotina de atendimento, apesar da limitação de tempo e recursos<sup>
<a href="#B49" class="usa-link" aria-describedby="B49">49</a>,<a href="#B50" class="usa-link" aria-describedby="B50">50</a>,<a href="#B51" class="usa-link" aria-describedby="B51">51</a>
</sup>. O suporte automatizado a decisões clínicas pode aproveitar os registros de saúde eletrônicos para identificar pessoas com DRC ou com alto risco de DRC e recomendar aos médicos as ações adequadas (<a href="#F4" class="usa-link">Figura 2</a>).</p>
<p>Atualmente, poucos países dispõem de registros de DRC, o que limita nossa capacidade de ressaltar o ônus da doença perante os governos. O conhecimento sobre o ônus da DRC auxilia na priorização das necessidades de saúde renal, que devem se expandir progressivamente de modo a abranger todo o espectro do cuidado renal<sup>
<a href="#B52" class="usa-link" aria-describedby="B52">52</a>
</sup>. Uma pesquisa global revelou que apenas um quarto dos países (41/162) tinha uma estratégia nacional específica para a DRC e menos de um terço (48/162) reconhecia a DRC como uma prioridade de saúde pública<sup>
<a href="#B23" class="usa-link" aria-describedby="B23">23</a>
</sup>. O reconhecimento da DRC pela OMS como um dos principais fatores de mortalidade por DNTs seria eficaz para aumentar a conscientização, melhorar a vigilância e o monitoramento locais visando à implementação de diretrizes de práticas clínicas, além de melhorar a alocação de recursos<sup>
<a href="#B2" class="usa-link" aria-describedby="B2">2</a>
</sup>.</p>
<p>Os programas para a detecção precoce da DRC exigirão ampla coordenação e envolvimento das partes interessadas, incluindo governos, sistemas de saúde e seguradoras. Organizações renais internacionais e nacionais, como a <em>International Society of Nephrology</em> (ISN), já defendem junto à OMS e a governos individuais a priorização da doença renal. Devemos dar continuidade a esse trabalho, colaborando para agilizar o planejamento e a implementação do programa de detecção precoce. A integração com programas comunitários existentes (por exemplo, prevenção de doenças cardiovasculares) em LMICs e HICs pode reduzir os custos e maximizar a eficiência. Tais programas precisarão ser adaptados ao contexto local e podem ser realizados em uma variedade de ambientes, como consultórios médicos individuais, hospitais, unidades de saúde regionais ou nacionais ou como alcance a comunidades rurais. Dependendo das regulamentações e dos recursos locais, a triagem e a detecção de casos também podem ocorrer fora de ambientes médicos, como prefeituras, igrejas ou feiras. Voluntários locais também podem auxiliar nos esforços de triagem e detecção de casos dentro da comunidade.</p>
<p>Paralelamente à reorientação da prática clínica dos profissionais de saúde para a detecção oportuna da DRC, devemos nos concentrar na educação da população em geral sobre o risco percebido e nas atividades de promoção da saúde e programas educacionais destinados a conscientizar e empoderar os pacientes. A conscientização sobre a doença renal é baixa, sendo que 9 em cada 10 pessoas com DRC desconhecem que são afetadas<sup>
<a href="#B53" class="usa-link" aria-describedby="B53">53</a>
</sup>. A doença renal é pouco abordada na mídia leiga, e uma análise revelou que ela foi 11 vezes menos representada em comparação à causa real do óbito<sup>
<a href="#B54" class="usa-link" aria-describedby="B54">54</a>
</sup>. Diversas organizações nacionais e internacionais desenvolveram questionários para o público em geral sobre o risco de doença renal. Esse fato foi apoiado por um estudo regional que demonstrou que pacientes socialmente vulneráveis com hipertensão não compreendem os riscos renais a que estão expostos<sup>
<a href="#B21" class="usa-link" aria-describedby="B21">21</a>,<a href="#B55" class="usa-link" aria-describedby="B55">55</a>,<a href="#B56" class="usa-link" aria-describedby="B56">56</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>. A educação, tanto online quanto presencial, voltada para os profissionais de saúde, pode melhorar a alfabetização em saúde do consumidor. A ativação, o comprometimento e a tomada de decisão compartilhada do paciente são impactos posteriores da conscientização. A conscientização sobre a DRC é diferenciada, incluindo a detecção e a estratificação de risco para informar e empoderar, em vez de amedrontar, quanto ao momento e à extensão das intervenções (ver <a href="#T2" class="usa-link">Quadro 1</a>)<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>,<a href="#B27" class="usa-link" aria-describedby="B27">27</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>. Encontrar o equilíbrio adequado otimizará a autoeficácia e o envolvimento de pacientes, familiares e cuidadores.</p>
<section class="tw xbox font-sm" id="T2"><h3 class="obj_head">Quadro 1. S<span class="font-variant-small-caps">eus rins estão saudáveis? perspectivas pessoais sobre conscientização, detecção e tratamento da</span> DRC <span class="font-variant-small-caps">com base na literatura</span>
<sup>
<a href="#B4" class="usa-link" aria-describedby="B4">4</a>,<a href="#B57" class="usa-link" aria-describedby="B57">57</a>
</sup>
.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Na verdade, eu não entendia muito bem por que ninguém tinha me dado todas as informações sobre o que eu tinha, de uma forma que eu pudesse dizer: “Bem, isso é o que eu tenho [DRC] e é por isso que eu tenho”.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Eles [os médicos] podem responder a essas perguntas [sobre saúde renal], (...) mas é tudo muito técnico.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Eu não sabia o que significava [DRC], então não podia realmente compartilhar com outras pessoas.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Talvez eu não saiba quais são meus índices [de saúde renal], mas sei quais são os exames e sei que já os fiz antes.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Bem, deixe-me dizer o seguinte: Agora eu estou bem ciente da importância dos rins e de quais são os problemas aqui. E eu certamente consideraria... Quando eu for ao médico, diria a ele: “Escute, o senhor fez os exames de sangue. Mas como estão os meus rins? Quais são os resultados?”</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Eu sei que eles fizeram exames de urina no passado, e sei que havia proteína e açúcar na minha urina.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Eu saí de nunca tomar um comprimido para tomar 22 comprimidos. O que está acontecendo aqui? Eu não sabia o que eram. Mas eu apenas os numerei e isso me ajudou muito porque percebi o que estava acontecendo, mas alguns deles, toda vez que eu ia lá [ao médico], eu recebia outro comprimido. Eu sabia que tinha de tomá-lo porque eles sabiam o que estavam fazendo, os médicos que eu consultava.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">Isso [DRC] é algo novo, então, imediatamente, eu estava pensando que era só mais uma coisa com que me preocupar. Mas depois me senti um pouco empoderado e como se eu realmente quisesse me antecipar a isso. Sinto que quero ter uma conversa com meu médico da atenção primária.</td></tr>
<tr><td align="left" valign="top" rowspan="1" colspan="1">O que mais me interessa é saber o que está acontecendo, por que está acontecendo e o que posso fazer para desacelerar isso [DRC]?</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec17"><h2 class="pmc_sec_title">Conclusão: um Chamado à Ação</h2>
<p>Convocamos todos os profissionais de saúde a avaliar a saúde renal de seus pacientes com risco de doença renal. Em paralelo, devemos trabalhar em conjunto com as organizações de saúde pública no sentido de melhorar a percepção da população em geral sobre o risco de desenvolver doença renal e capacitar os indivíduos em risco a buscar acompanhamento da saúde renal. Para viabilizar essa mudança, precisamos atuar junto aos sistemas de saúde, aos governos e à OMS para priorizar a doença renal e criar programas eficazes e eficientes de detecção precoce da doença renal. Só então os benefícios da mudança de paradigma decorrentes das alterações no estilo de vida e dos tratamentos farmacológicos se traduzirão em melhor saúde renal e geral para as pessoas em todo o mundo.</p></section><section id="ack2" class="ack"><h2 class="pmc_sec_title">Agradecimentos</h2>
<p>Os autores agradecem aos membros do Comitê Diretivo Conjunto do Dia Mundial do Rim — Valerie A. Luyckx, Marcello Tonelli, Ifeoma Ulasi, Vivekanand Jha, Marina Wainstein, Siddiq Anwar, Daniel O’Hara, Elliot K. Tannor, Jorge Cerda, Elena Cervantes e María Carlota González Bedat — pelas contribuições valiosas a este artigo.</p></section><section id="sec18"><h2 class="pmc_sec_title">Disponibilidade de Dados</h2>
<p>Não há novos dados associados a este artigo.</p></section></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>There is no new data associated with this article.</p>
<p>Não há novos dados associados a este artigo.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Jornal Brasileiro de Nefrologia are provided here courtesy of <strong>Sociedade Brasileira de Nefrologia</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1590/2175-8239-JBN-2025-0106en"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/2175-8239-jbn-47-4-e20250106.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (429.6 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12233814/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12233814/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12233814%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12233814/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12233814/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12233814/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40623116/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12233814/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40623116/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12233814/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12233814/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="wE1rPIeu7jrFNyKpi2B0f1rCCqpGKFxTmCwSakSqTYFdfFcIa3jOutFsMMvvQENv">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
